Targeting C‐type lectin receptors: a high‐carbohydrate diet for dendritic cells to improve cancer vaccines

Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of vaccines. There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of leukocyte biology Jg. 102; H. 4; S. 1017 - 1034
Hauptverfasser: Dinther, Dieke, Stolk, Dorian A., Ven, Rieneke, Kooyk, Yvette, Gruijl, Tanja D., Haan, Joke M. M.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Bethesda, MD, USA Society for Leukocyte Biology 01.10.2017
Oxford University Press
Schlagworte:
Animals
Antibodies
Anticancer properties
Antigen (tumor-associated)
antigen presentation
Antigen-presenting cells
Antigens
Antitumor activity
Cancer
Cancer vaccines
Cancer Vaccines - genetics
Cancer Vaccines - immunology
Cancer Vaccines - therapeutic use
Carbohydrates
Cytotoxicity
Dendritic cells
Dendritic Cells - immunology
Humans
Immune checkpoint
Immune response
Immune system
Immunotherapy
Lectins
Lectins, C-Type - genetics
Lectins, C-Type - immunology
Lymphocytes
Lymphocytes T
Macrophages
Neoplasms - genetics
Neoplasms - immunology
Neoplasms - therapy
Priming
Receptors
Reviews
T cell receptors
T cells
T-Lymphocytes, Helper-Inducer - immunology
Vaccines
macrophages
antigen presentation
T cells
antigen presenting cells
ISSN:0741-5400, 1938-3673, 1938-3673
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of vaccines. There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C‐type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen‐specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate‐recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.
AbstractList There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C-type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen-specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate-recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.
Review of in vivo targeting of tumor antigens to lectin receptors on antigen-presenting cells using antibodies or ligands may improve the antitumor efficacy of vaccines. There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C-type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen-specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate-recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.
Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of vaccines. There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C‐type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen‐specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate‐recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.
There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C-type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen-specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate-recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and redevelop vaccine strategies to prime an anticancer immune response. Combination of such vaccines with checkpoint inhibitors will both provide the fuel and release the brake for an efficient anticancer response. Here, we discuss vaccine strategies that use C-type lectin receptor (CLR) targeting of APCs, such as dendritic cells and macrophages. APCs are a necessity for the priming of antigen-specific cytotoxic and helper T cells. Because CLRs are natural carbohydrate-recognition receptors highly expressed by multiple subsets of APCs and involved in uptake and processing of Ags for presentation, these receptors seem particularly interesting for targeting purposes.
Author Dinther, Dieke
Ven, Rieneke
Kooyk, Yvette
Stolk, Dorian A.
Gruijl, Tanja D.
Haan, Joke M. M.
Author_xml – sequence: 1
  givenname: Dieke
  surname: Dinther
  fullname: Dinther, Dieke
– sequence: 2
  givenname: Dorian A.
  surname: Stolk
  fullname: Stolk, Dorian A.
– sequence: 3
  givenname: Rieneke
  surname: Ven
  fullname: Ven, Rieneke
– sequence: 4
  givenname: Yvette
  surname: Kooyk
  fullname: Kooyk, Yvette
– sequence: 5
  givenname: Tanja D.
  surname: Gruijl
  fullname: Gruijl, Tanja D.
– sequence: 6
  givenname: Joke M. M.
  surname: Haan
  fullname: Haan, Joke M. M.
  email: j.denhaan@vumc.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28729358$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1uEzEUhS1URNPCA7BBltiwmWKP7fGYBVKJ-FUQUlTWlse-kzia2MF2grLjEXhGnoQJCRV0AStL937n-hydC3QWYgCEHlNyRWmrnq-G7kp8nJOayooINZ_fQxOqWFuxRrIzNCGS00pwQs7RRc4rQgirG_IAndetrBUT7QSFG5MWUHxY4OmPb9_LfgN4ADsOcAILmxJTfoENXvrFctxbk7q43LtkCmDnoeA-JuwguOSLt9jCMGRcIvbrTYo7wNYECwnvjLU-QH6I7vdmyPDo9F6iz29e30zfVbNPb99Pr2eVHe3KSqhethw4t4abrnNUmoZ0QgjWkVaa2vZ1z03NrGNGMSWcoT1nthfO0cYSzi7Ry-PdzbZbg7MQSjKD3iS_Nmmvo_H6703wS72IOy2EkoIeDjw7HUjxyxZy0WufD-lMgLjNmqq6FkQyJUf06R10FbcpjPFGqmWc1YSKkXryp6NbK7-rGAF6BGyKOSfobxFK9KFuPdatT3XrX3WPGnlHY30xxcdDKD_8U9kclV_9APv_f6U_zF5RQiX7CT7wxTU
CitedBy_id crossref_primary_10_1016_j_molimm_2019_07_022
crossref_primary_10_3390_cancers11030418
crossref_primary_10_3390_pharmaceutics16050581
crossref_primary_10_1038_s41541_020_00227_x
crossref_primary_10_1002_ejoc_202000587
crossref_primary_10_3389_fonc_2023_1301473
crossref_primary_10_1111_imr_12662
crossref_primary_10_1080_03639045_2019_1593442
crossref_primary_10_3390_cancers11091266
crossref_primary_10_2174_0118742203270381240209060006
crossref_primary_10_3389_fimmu_2024_1490003
crossref_primary_10_3389_fimmu_2020_00990
crossref_primary_10_1016_j_pnmrs_2024_10_002
crossref_primary_10_1016_j_actbio_2019_04_033
crossref_primary_10_1111_febs_15830
crossref_primary_10_1016_j_jconrel_2021_04_012
crossref_primary_10_1039_D2NR07071E
crossref_primary_10_1073_pnas_2006186117
crossref_primary_10_1016_j_omto_2021_04_009
crossref_primary_10_1111_imm_13801
crossref_primary_10_1177_1758835920987056
crossref_primary_10_3390_cancers12030590
crossref_primary_10_1158_2326_6066_CIR_19_0210
crossref_primary_10_1146_annurev_immunol_041015_055523
crossref_primary_10_3390_cancers15082206
crossref_primary_10_3389_fimmu_2022_1040600
crossref_primary_10_1021_jacs_1c07235
crossref_primary_10_1088_2516_1091_ade212
crossref_primary_10_1007_s11033_024_10164_w
crossref_primary_10_1021_jacs_4c11091
crossref_primary_10_1016_j_biomaterials_2024_122628
crossref_primary_10_1016_j_imlet_2017_11_003
crossref_primary_10_1111_imm_13717
crossref_primary_10_1016_j_coi_2018_03_019
crossref_primary_10_3389_fimmu_2018_00471
crossref_primary_10_1002_eji_202149670
crossref_primary_10_1002_JLB_1MA0220_337RR
crossref_primary_10_1002_cbic_202000687
crossref_primary_10_1016_j_cbpa_2019_10_001
crossref_primary_10_1186_s12951_021_01129_3
crossref_primary_10_1016_j_biotechadv_2023_108144
crossref_primary_10_1007_s00262_020_02805_3
crossref_primary_10_2174_0929867326666190620103105
crossref_primary_10_3390_cancers11020183
crossref_primary_10_1002_adfm_202508761
crossref_primary_10_1111_all_15004
crossref_primary_10_3389_fimmu_2020_00134
crossref_primary_10_3389_fimmu_2018_01997
crossref_primary_10_3389_fimmu_2021_719664
crossref_primary_10_1016_j_mtchem_2020_100417
crossref_primary_10_3389_fimmu_2018_01231
crossref_primary_10_1016_j_semcancer_2020_02_005
crossref_primary_10_1016_j_ijpharm_2024_124254
crossref_primary_10_3390_pharmaceutics12070663
crossref_primary_10_1111_imm_13787
crossref_primary_10_3389_fimmu_2018_03176
crossref_primary_10_1016_j_apsb_2022_03_017
crossref_primary_10_3390_cancers14081854
Cites_doi 10.1007/s00262-011-1039-x
10.1016/j.ccell.2014.09.007
10.1002/eji.201344076
10.1182/blood-2005-01-0318
10.1158/1078-0432.CCR-07-0050
10.1146/annurev.immunol.22.012703.104558
10.1021/ar700108g
10.4049/jimmunol.176.1.426
10.1016/j.imlet.2013.12.001
10.1158/1078-0432.CCR-10-3421
10.4049/jimmunol.168.2.782
10.1016/j.it.2013.06.001
10.1038/ni1390
10.1016/j.immuni.2009.06.025
10.1002/jgm.910
10.1038/jid.2009.343
10.1084/jem.20161135
10.4049/jimmunol.1300787
10.1517/14712598.4.12.1953
10.4049/jimmunol.156.1.128
10.1021/bc8002524
10.1182/blood-2010-06-288068
10.1084/jem.184.5.1953
10.3390/vaccines4020008
10.1016/j.immuni.2016.08.015
10.1189/jlb.1HI0714-351R
10.1111/cas.12824
10.1111/sji.12387
10.4049/jimmunol.176.7.4431
10.1016/j.cell.2007.10.046
10.1038/ni.2705
10.1016/j.biomaterials.2011.03.015
10.1016/j.cell.2015.08.004
10.1158/1078-0432.CCR-15-1399
10.1002/eji.200737578
10.4049/jimmunol.181.4.2455
10.1038/jid.2015.152
10.1084/jem.20160597
10.1016/j.vaccine.2016.04.002
10.1016/j.immuni.2013.08.029
10.1038/nature06175
10.1038/nri3683
10.1182/blood-2010-01-264960
10.1038/nri3865
10.1016/j.vaccine.2016.08.071
10.1182/blood-2007-03-081398
10.1016/0264-410X(95)00258-3
10.1016/j.ccell.2016.06.003
10.1093/intimm/dxh246
10.1038/ni.3108
10.1158/1078-0432.CCR-05-2431
10.1007/s11095-011-0459-9
10.1016/j.molimm.2004.09.034
10.1016/j.jconrel.2008.03.023
10.1038/nature07750
10.1097/CJI.0000000000000035
10.1186/s40425-017-0218-5
10.1073/pnas.1219888110
10.1016/j.jdermsci.2014.08.012
10.1111/exd.12573
10.1126/science.1170540
10.15252/emmm.201303283
10.1002/eji.201343429
10.1016/S0092-8674(00)80693-5
10.1371/journal.pone.0040208
10.1084/jem.20131675
10.1126/science.1257530
10.1182/blood.V95.11.3489
10.1002/eji.201141855
10.1038/nri2056
10.1016/S1074-7613(02)00365-5
10.1158/0008-5472.CAN-11-0804
10.1172/JCI119825
10.1016/j.it.2013.03.001
10.1038/ni.3200
10.1084/jem.20071733
10.1111/j.1749-6632.2011.06392.x
10.1189/jlb.0608352
10.1038/nchembio.1186
10.1074/jbc.M110.113613
10.1038/nm.3773
10.1097/00002371-200103000-00012
10.1126/science.1136080
10.1158/0008-5472.CAN-03-3251
10.18632/oncotarget.9624
10.1002/eji.201141526
10.1038/nature13954
10.1038/ni.2419
10.1016/j.cell.2010.09.039
10.1016/j.molimm.2016.12.010
10.1126/scitranslmed.3008068
10.1182/blood-2008-05-158469
10.1016/j.immuni.2010.12.011
10.1038/nri2622
10.1038/cmi.2015.87
10.1172/jci.insight.87102
10.1084/jem.20100348
10.1038/ni.2360
10.1371/journal.pone.0070237
10.1158/0008-5472.CAN-07-1035
10.1126/sciimmunol.aai7677
10.1093/intimm/dxl022
10.1182/blood-2007-07-100750
10.1371/journal.pone.0052875
10.3389/fimmu.2015.00534
10.1016/j.jconrel.2015.01.040
10.1038/ni1462
10.1016/j.immuni.2013.04.011
10.1158/2326-6066.CIR-16-0001
10.1371/journal.pntd.0002330
10.1021/bc070026g
10.1093/glycob/cwg045
10.1016/j.immuni.2012.04.012
10.1016/j.immuni.2012.10.016
10.1126/science.1164206
10.1038/mi.2012.89
10.1021/acs.molpharmaceut.5b00072
10.1158/1078-0432.CCR-03-0264
10.1002/eji.200636838
10.1016/S0264-410X(00)00090-6
10.1074/jbc.M313127200
10.1371/journal.pone.0039039
10.4049/jimmunol.181.5.3148
10.1021/jm901295s
10.4049/jimmunol.174.11.6592
10.4049/jimmunol.163.4.1973
10.1002/eji.201445127
10.1200/JCO.2014.59.4358
10.1002/eji.201040790
10.1084/jem.192.12.1685
10.1002/anie.201201114
10.1182/blood-2011-03-344838
10.4049/jimmunol.168.5.2118
10.1002/eji.200738057
10.1586/erv.11.20
10.1002/eji.201344094
10.1038/nbt1390
10.1073/pnas.1609376113
10.4049/jimmunol.1300975
10.1038/ni.2967
10.4161/onci.28836
10.1002/eji.200838470
10.1084/jem.20111457
10.1016/j.molimm.2008.11.021
10.1158/0008-5472.CAN-12-2583
10.1016/j.immuni.2009.08.010
10.1084/jem.20091586
10.1189/jlb.0512231
10.3389/fimmu.2013.00403
10.1016/j.immuni.2015.07.020
10.1097/CJI.0b013e318135472c
10.1182/blood-2010-04-279133
10.1158/1078-0432.CCR-09-1624
10.1158/1078-0432.CCR-08-1474
10.1007/s002800000179
10.1084/jem.20100223
10.1016/j.immuni.2016.12.001
10.1182/blood-2011-08-373944
10.1371/journal.pone.0016827
10.1038/cti.2014.14
10.1084/jem.20091627
10.4049/jimmunol.1600011
10.7554/eLife.00757
10.1158/2326-6066.CIR-14-0149
10.1084/jem.20092618
10.1073/pnas.1423356112
10.4049/jimmunol.1101176
10.1097/MOH.0000000000000202
10.1182/blood-2010-02-268425
10.1038/nri2173
10.1038/nri1669
10.1097/CJI.0000000000000067
10.1016/j.imbio.2006.06.009
10.1016/S1074-7613(00)80160-0
10.1007/s00281-013-0378-4
10.4049/jimmunol.1400489
10.1016/bs.ai.2015.03.002
10.1016/j.immuni.2012.03.008
10.1074/jbc.M202104200
10.1126/science.1137971
10.1182/blood-2012-12-473413
10.1002/eji.201040762
10.1016/j.immuni.2009.08.027
10.1189/jlb.0711384
10.1016/j.vaccine.2011.04.076
10.1084/jem.20032220
10.1002/eji.201444983
10.1016/j.vaccine.2003.11.008
10.1016/j.biomaterials.2012.02.036
10.1146/annurev-immunol-032713-120204
10.1038/ni.3341
10.1084/jem.20021263
10.1182/blood-2005-08-3264
10.1016/j.biomaterials.2016.10.047
10.4049/jimmunol.180.6.3647
10.1038/ncomms13324
10.1084/jem.20120774
10.1111/j.1365-2567.2007.02554.x
10.1158/2326-6066.CIR-14-0165
10.4049/jimmunol.0900464
10.1073/pnas.1319268111
10.1038/nri3712
10.4161/21624011.2014.970462
10.1158/1078-0432.CCR-15-2205
10.1186/1471-2172-14-39
10.3389/fimmu.2013.00157
10.1002/j.1460-2075.1994.tb06771.x
10.1002/j.1460-2075.1991.tb07689.x
10.1073/pnas.0910295106
10.1186/1479-5876-5-5
10.1016/j.immuni.2012.11.001
10.1016/j.jconrel.2014.07.040
10.1189/jlb.1107750
10.1016/j.jconrel.2012.02.007
10.1182/blood-2004-03-0878
10.1074/jbc.274.27.19087
10.1016/j.immuni.2015.04.017
10.1093/intimm/dxh089
10.1073/pnas.0909541107
10.4049/jimmunol.1000999
10.1016/j.immuni.2008.07.013
10.1084/jem.20120340
10.4049/jimmunol.177.4.2276
10.1084/jem.194.6.769
10.1016/j.immuni.2007.07.021
10.1016/j.celrep.2016.05.025
10.1111/j.1600-0625.2010.01146.x
10.1056/NEJMoa1100066
10.1084/jem.20021598
10.1038/ni.1615
10.1038/ni.2370
10.1002/eji.201242847
10.1038/ni.1601
10.1084/jem.20121103
10.1182/blood-2002-04-1088
10.1002/eji.201142086
10.4049/jimmunol.1303029
10.1016/j.immuni.2016.03.012
10.1016/j.jim.2016.02.023
10.4049/jimmunol.1301661
10.1016/j.bbrc.2009.11.173
10.4049/jimmunol.1200598
10.1016/j.immuni.2014.08.006
10.4049/jimmunol.172.5.2845
10.4049/jimmunol.176.12.7232
10.4049/jimmunol.180.7.4540
10.1016/j.cell.2008.09.016
10.1016/j.molimm.2009.09.026
10.1158/0008-5472.CAN-04-0138
10.1146/annurev-immunol-051116-052215
10.1016/j.immuni.2012.07.019
10.1074/jbc.M709923200
10.1182/blood-2008-03-146290
10.1371/journal.pone.0103755
10.1007/s00262-016-1811-z
10.1182/blood-2011-09-382200
10.1093/glycob/cwq193
10.1172/JCI34584
10.1172/JCI60644
10.4049/jimmunol.180.10.6836
10.4049/jimmunol.1202937
10.1002/ijc.23101
10.1051/vetres:2008052
10.1016/j.immuni.2012.08.026
10.1002/ijc.25458
10.1158/1078-0432.CCR-11-0891
10.1097/CJI.0b013e31812e6256
10.1200/JCO.2016.34.15_suppl.9589
10.1371/journal.pone.0155189
10.1016/S0002-9440(10)61217-5
10.1126/science.aaa4971
10.1182/blood-2008-05-155176
10.4049/jimmunol.1000808
10.1073/pnas.1019547108
10.1182/blood-2011-04-346957
10.1182/blood-2012-01-406967
10.1016/j.immuni.2013.10.004
10.1046/j.0022-202x.2001.01633.x
ContentType Journal Article
Copyright 2017 Society for Leukocyte Biology
The Author(s).
Copyright Federation of American Societies for Experimental Biology (FASEB) Oct 2017
The Author(s) 2017 Society for Leukocyte Biology
Copyright_xml – notice: 2017 Society for Leukocyte Biology
– notice: The Author(s).
– notice: Copyright Federation of American Societies for Experimental Biology (FASEB) Oct 2017
– notice: The Author(s) 2017 Society for Leukocyte Biology
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
5PM
DOI 10.1189/jlb.5MR0217-059RR
DatabaseName Wiley Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE


CrossRef
MEDLINE - Academic
Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1938-3673
EndPage 1034
ExternalDocumentID PMC5597514
28729358
10_1189_jlb_5MR0217_059RR
JLB1017
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Dutch Cancer Society
  funderid: VU2013‐5940; VU2016‐10449; VU2015‐7864; VU2014‐7200
GroupedDBID ---
.GJ
0R~
0VX
18M
1OC
24P
29K
2WC
33P
4.4
53G
5GY
5RE
5WD
AABZA
AACZT
AAMMB
AAPGJ
AAPXW
AARHZ
AASGY
AAUAY
AAVAP
AAWDT
AAXRX
AAZKR
ABCUV
ABDFA
ABEFU
ABEJV
ABGNP
ABIME
ABJNI
ABLJU
ABMNT
ABNHQ
ABPIB
ABPQP
ABPTD
ABVGC
ABWST
ABXVV
ABXZS
ABZEO
ACAHQ
ACCZN
ACFRR
ACGFO
ACGFS
ACPOU
ACPRK
ACUTJ
ACVCV
ACXBN
ACXQS
ACZBC
ADBBV
ADGKP
ADIPN
ADKYN
ADMTO
ADNBA
ADOZA
ADQBN
ADVEK
ADVOB
ADXAS
ADZMN
AEFGJ
AENEX
AFFNX
AFFQV
AFGWE
AFRAH
AFYAG
AGMDO
AGQXC
AGXDD
AHGBF
AHMMS
AI.
AIDQK
AIDYY
AIQQE
AIURR
AJAOE
AJBYB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALXQX
AMYDB
ANFBD
APJGH
ATGXG
AVNTJ
BCRHZ
C45
CS3
D-I
DCZOG
DRFUL
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
F5P
F9R
GX1
H13
HZ~
K-O
KOP
L7B
LATKE
LEEKS
LUTES
LYRES
NU-
O9-
OBFPC
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P2W
RJQFR
ROL
ROX
SJN
SUPJJ
TCN
TEORI
TMA
TR2
TSL
VH1
W8F
WOHZO
WOQ
YHG
ZGI
ZXP
ZZTAW
AAYXX
CITATION
AGORE
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T5
7T7
7U9
8FD
C1K
FR3
H94
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c5407-59f784e44ca4abbd17a60b5553b087a2cf2f4a23cd3a9395da1f43cf5dd16c043
IEDL.DBID 24P
ISICitedReferencesCount 66
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000413396400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0741-5400
1938-3673
IngestDate Tue Sep 30 15:00:30 EDT 2025
Sun Sep 28 12:22:42 EDT 2025
Sat Jul 26 02:19:02 EDT 2025
Mon Jul 21 06:09:14 EDT 2025
Sat Nov 29 01:44:47 EST 2025
Tue Nov 18 22:37:52 EST 2025
Sun Sep 21 06:19:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords macrophages
antigen presentation
T cells
antigen presenting cells
Language English
License Attribution-NonCommercial
https://creativecommons.org/licenses/by-nc/4.0
The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) (http://creativecommons.org/licenses/by-nc/4.0/) which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5407-59f784e44ca4abbd17a60b5553b087a2cf2f4a23cd3a9395da1f43cf5dd16c043
Notes These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1189%2Fjlb.5MR0217-059RR
PMID 28729358
PQID 1983432015
PQPubID 2046249
PageCount 18
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5597514
proquest_miscellaneous_1922507397
proquest_journals_1983432015
pubmed_primary_28729358
crossref_primary_10_1189_jlb_5MR0217_059RR
crossref_citationtrail_10_1189_jlb_5MR0217_059RR
wiley_primary_10_1189_jlb_5MR0217_059RR_JLB1017
PublicationCentury 2000
PublicationDate October 2017
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: October 2017
PublicationDecade 2010
PublicationPlace Bethesda, MD, USA
PublicationPlace_xml – name: Bethesda, MD, USA
– name: England
– name: Bethesda
PublicationTitle Journal of leukocyte biology
PublicationTitleAlternate J Leukoc Biol
PublicationYear 2017
Publisher Society for Leukocyte Biology
Oxford University Press
Publisher_xml – name: Society for Leukocyte Biology
– name: Oxford University Press
References 2004; 22
2005; 174
2011; 118
2017; 81
1991; 10
2008; 38
2004; 4
2016; 30
2010; 185
2013; 121
2012; 13
2006; 211
2016; 34
2000; 18
2012; 1253
2011; 128
2000; 12
2015; 135
2008; 29
2016; 432
2008; 26
2008; 118
2013; 110
2008; 112
2008; 111
2011; 365
2016; 45
2016; 44
2007; 18
2015; 127
2009; 182
2008; 129
2010; 285
2012; 37
2012; 36
2016; 17
2008; 122
2011; 6
2001; 24
2016; 15
2012; 33
2007; 13
2000; 192
2016; 11
2016; 4
2016; 7
2016; 1
2013; 73
2015; 112
2005; 5
2013; 210
1994; 13
2008; 41
2008; 135
2016; 213
2006; 107
2012; 42
2016; 23
2016; 22
2004; 64
2010; 53
2008; 9
2010; 143
2002; 118
2007; 30
2017; 113
2007; 37
2012; 209
2013; 14
2014; 4
2014; 3
2017; 35
2007; 131
2016; 113
2010; 391
2009; 206
2014; 9
2014; 6
2009; 324
2007; 27
2015; 162
2014; 515
2015; 6
2015; 3
2006; 12
2013; 43
2015; 97
2007; 121
2009
2006; 18
2014; 192
2008; 322
2014; 193
2004; 199
2011; 108
2013; 39
2013; 38
2017; 14
2013; 35
2005; 167
2013; 34
1999; 274
2009; 9
2010; 130
2016
2008; 85
2008; 84
2002; 17
2013; 4
2012; 122
2013; 2
2010; 107
2015; 77
2011; 61
2002; 277
2000; 95
2014; 26
2006; 176
1999; 163
2013; 7
2013; 8
2013; 6
2014; 23
2006; 177
2013; 9
2015; 82
2010; 116
2011; 71
2004; 172
2005; 106
2007; 8
2014; 15
2014; 14
2007; 7
2007; 5
2013; 191
2007; 67
2009; 15
2013; 190
2007; 449
2007; 204
2010; 207
2014; 41
1996; 14
2014; 158
2014; 44
2009; 458
2012; 351
2007; 316
2004; 279
2007; 315
2014; 37
2000; 100
2005; 17
2003; 101
2012; 119
2009; 106
2017; 5
2009; 47
2009; 46
2015; 38
2009; 40
2002; 196
2000; 46
2015; 33
2012; 160
1996; 184
2003; 13
2011; 10
2015; 106
2015; 348
2011; 17
2012; 51
2015; 45
2015; 212
2015; 42
1997; 100
2015; 43
2011; 20
2011; 21
2011; 28
2011; 29
2016; 197
2015; 12
2015; 15
2015; 16
2004; 104
2015; 203
2008; 19
2008; 14
2006; 7
2006; 8
2005; 42
2011; 32
2011; 34
2014; 111
2008; 283
2004; 10
2008; 181
2008; 180
2012; 92
2012; 91
2001; 194
2009; 31
2004; 16
2002; 168
2015; 21
2016; 65
2011; 41
2012; 7
1996; 156
2014; 346
2011; 187
2011; 186
Cruz (2023013012234150500_B146) 2014; 192
Chappell (2023013012234150500_B61) 2012; 209
Valladeau (2023013012234150500_B191) 2002; 168
Iijima (2023013012234150500_B76) 2014; 346
Tsuji (2023013012234150500_B152) 2011; 186
Diebold (2023013012234150500_B208) 1999; 274
Macho-Fernandez (2023013012234150500_B145) 2014; 193
Hoeffel (2023013012234150500_B90) 2012; 209
Kojima (2023013012234150500_B218) 2008; 129
Bogunovic (2023013012234150500_B42) 2009; 31
Napoletano (2023013012234150500_B247) 2007; 67
Meyer-Wentrup (2023013012234150500_B131) 2008; 111
Xie (2023013012234150500_B188) 2010; 391
Thomann (2023013012234150500_B211) 2011; 32
Seré (2023013012234150500_B96) 2012; 37
Unger (2023013012234150500_B232) 2012; 160
Mebius (2023013012234150500_B79) 2005; 5
Maraskovsky (2023013012234150500_B17) 1996; 184
Bain (2023013012234150500_B44) 2013; 6
Backer (2023013012234150500_B81) 2010; 107
Bonifaz (2023013012234150500_B136) 2002; 196
Sancho (2023013012234150500_B173) 2009; 458
Hildner (2023013012234150500_B29) 2008; 322
Duluc (2023013012234150500_B185) 2014; 192
Johnson (2023013012234150500_B140) 2008; 14
Geijtenbeek (2023013012234150500_B119) 2004; 22
Artyomov (2023013012234150500_B197) 2015; 212
Hamdy (2023013012234150500_B219) 2011; 28
Romano (2023013012234150500_B98) 2012; 119
Vuylsteke (2023013012234150500_B114) 2006; 12
Srinivas (2023013012234150500_B238) 2007; 18
Hambleton (2023013012234150500_B31) 2011; 365
Shi (2023013012234150500_B212) 2017; 113
Garcia-Vallejo (2023013012234150500_B222) 2013; 34
Sheng (2023013012234150500_B216) 2008; 38
Cheong (2023013012234150500_B151) 2010; 116
Gautier (2023013012234150500_B20) 2012; 13
Macri (2023013012234150500_B181) 2017; 81
Burgdorf (2023013012234150500_B200) 2007; 316
Bonifaz (2023013012234150500_B135) 2004; 199
Ramakrishna (2023013012234150500_B202) 2007; 5
Keler (2023013012234150500_B201) 2004; 4
Cisse (2023013012234150500_B13) 2008; 135
Singh (2023013012234150500_B245) 2011; 128
Van den Berg (2023013012234150500_B124) 2012; 1253
Pantel (2023013012234150500_B147) 2012; 42
Bain (2023013012234150500_B40) 2014; 15
McGovern (2023013012234150500_B108) 2014; 41
Freire (2023013012234150500_B246) 2010; 116
Molenkamp (2023013012234150500_B270) 2005; 167
Lindenberg (2023013012234150500_B109) 2013; 8
Ni (2023013012234150500_B184) 2010; 185
Poderoso (2023013012234150500_B254) 2011; 29
Kumamoto (2023013012234150500_B58) 2013; 39
Segura (2023013012234150500_B67) 2013; 34
Aarnoudse (2023013012234150500_B237) 2008; 122
Tamoutounour (2023013012234150500_B107) 2013; 39
Birkholz (2023013012234150500_B156) 2010; 116
Segura (2023013012234150500_B117) 2013; 210
Henriques (2023013012234150500_B160) 2013; 7
Bergsbaken (2023013012234150500_B77) 2015; 16
Hattori (2023013012234150500_B213) 2006; 8
Tumeh (2023013012234150500_B3) 2014; 515
Schiavoni (2023013012234150500_B35) 2002; 196
Martin (2023013012234150500_B280) 2016; 11
Sancho (2023013012234150500_B27) 2008; 118
Sluijter (2023013012234150500_B116) 2015; 3
Varol (2023013012234150500_B41) 2009; 31
Van Vliet (2023013012234150500_B250) 2008; 181
Santegoets (2023013012234150500_B112) 2008; 180
Higashi (2023013012234150500_B241) 2002; 277
Ahrens (2023013012234150500_B172) 2012; 36
Hangalapura (2023013012234150500_B269) 2011; 71
Idoyaga (2023013012234150500_B194) 2011; 108
Clausen (2023013012234150500_B89) 2015; 6
Perdiguero (2023013012234150500_B39) 2016; 17
Hutten (2023013012234150500_B6) 2014; 37
Zelenay (2023013012234150500_B171) 2012; 122
Schreibelt (2023013012234150500_B169) 2012; 119
Guilliams (2023013012234150500_B22) 2014; 14
Cummings (2023013012234150500_B121) 2009
Wolchok (2023013012234150500_B265) 2009; 15
Tamoutounour (2023013012234150500_B45) 2012; 42
Schlitzer (2023013012234150500_B37) 2015; 16
Asano (2023013012234150500_B257) 2011; 34
Morse (2023013012234150500_B260) 2011; 17
Van den Hout (2023013012234150500_B115) 2016; 65
Linnemann (2023013012234150500_B279) 2015; 21
Hutten (2023013012234150500_B182) 2016; 197
Marshall (2023013012234150500_B175) 2004; 279
Dhodapkar (2023013012234150500_B264) 2014; 6
Kobiyama (2023013012234150500_B189) 2014; 111
Salmon (2023013012234150500_B57) 2016; 44
Barbuto (2023013012234150500_B150) 2013; 9
Poulin (2023013012234150500_B163) 2012; 119
Schlitzer (2023013012234150500_B62) 2013; 38
Apostolopoulos (2023013012234150500_B207) 2014; 3
Menezes (2023013012234150500_B48) 2016; 45
Kanitakis (2023013012234150500_B94) 2011; 20
Apostolopoulos (2023013012234150500_B205) 1996; 14
Martinez-Pomares (2023013012234150500_B83) 2007; 131
Lahoud (2023013012234150500_B179) 2009; 182
Jung (2023013012234150500_B52) 2002; 17
Napoletano (2023013012234150500_B248) 2012; 42
Crocker (2023013012234150500_B251) 2007; 7
Lahoud (2023013012234150500_B167) 2011; 187
Van Buuren (2023013012234150500_B278) 2014; 3
Ott (2023013012234150500_B2) 2017; 5
Van Vliet (2023013012234150500_B249) 2006; 7
Klechevsky (2023013012234150500_B162) 2010; 116
Hoeffel (2023013012234150500_B50) 2007; 27
Hesse (2023013012234150500_B229) 2013; 43
Segura (2023013012234150500_B106) 2012; 209
Haniffa (2023013012234150500_B110) 2015; 77
Segura (2023013012234150500_B71) 2014; 158
Clark (2023013012234150500_B85) 2006; 176
Heeren (2023013012234150500_B118) 2015; 3
Molenkamp (2023013012234150500_B272) 2006; 211
Crozat (2023013012234150500_B23) 2010; 207
Spranger (2023013012234150500_B4) 2016; 113
Waskow (2023013012234150500_B18) 2008; 9
Haniffa (2023013012234150500_B99) 2012; 37
Srinivas (2023013012234150500_B214) 2010; 53
Poulin (2023013012234150500_B26) 2010; 207
Brown (2023013012234150500_B120) 2016
Wang (2023013012234150500_B234) 2007; 121
Flacher (2023013012234150500_B195) 2010; 130
Pereira (2023013012234150500_B231) 2007; 30
Schreibelt (2023013012234150500_B10) 2016; 22
Murphy (2023013012234150500_B63) 2016; 34
Van Vliet (2023013012234150500_B243) 2007; 37
Meixlsperger (2023013012234150500_B157) 2013; 121
Bachem (2023013012234150500_B24) 2010; 207
Aliberti (2023013012234150500_B33) 2003; 101
Lehmann (2023013012234150500_B137) 2016; 4
Bates (2023013012234150500_B127) 1999; 163
Picco (2023013012234150500_B164) 2014; 44
Crocker (2023013012234150500_B253) 1991; 10
Van de Ven (2023013012234150500_B105) 2011; 118
Singh (2023013012234150500_B133) 2009; 46
Yi (2023013012234150500_B60) 2013; 2
Meyer-Wentrup (2023013012234150500_B130) 2008; 85
Donadei (2023013012234150500_B186) 2015; 12
Carpentier (2023013012234150500_B97) 2016; 432
Plantinga (2023013012234150500_B47) 2013; 38
Breton (2023013012234150500_B38) 2016; 213
Roberts (2023013012234150500_B55) 2016; 30
Den Brok (2023013012234150500_B274) 2016; 7
Fehres (2023013012234150500_B104) 2017; 14
Den Haan (2023013012234150500_B78) 2013; 35
Tacken (2023013012234150500_B225) 2005; 106
Fehres (2023013012234150500_B239) 2015; 135
Segura (2023013012234150500_B70) 2015; 127
Molenkamp (2023013012234150500_B271) 2007; 13
Kato (2023013012234150500_B153) 2006; 18
Liu (2023013012234150500_B16) 2009; 324
Den Haan (2023013012234150500_B53) 2000; 192
Lundberg (2023013012234150500_B72) 2013; 8
Davies (2023013012234150500_B75) 2013; 14
Tel (2023013012234150500_B154) 2011; 41
Nagasawa (2023013012234150500_B14) 2008; 38
McKenna (2023013012234150500_B19) 2000; 95
Van de Ven (2023013012234150500_B74) 2013; 4
Bol (2023013012234150500_B5) 2016; 22
Graham (2023013012234150500_B158) 2016; 34
Dakappagari (2023013012234150500_B224) 2006; 176
Chari (2023013012234150500_B138) 2008; 41
Idoyaga (2023013012234150500_B102) 2008; 180
Veninga (2023013012234150500_B80) 2015; 45
Cruz (2023013012234150500_B240) 2012; 33
Edelson (2023013012234150500_B30) 2010; 207
Bhardwaj (2023013012234150500_B266) 2016; 34
Bigley (2023013012234150500_B193) 2015; 97
Collin (2023013012234150500_B95) 2016; 23
Swiecki (2023013012234150500_B49) 2015; 15
Martinez-Pomares (2023013012234150500_B126) 2012; 92
Stambach (2023013012234150500_B122) 2003; 13
Segura (2023013012234150500_B69) 2009; 106
Denda-Nagai (2023013012234150500_B244) 2010; 285
Kawasaki (2023013012234150500_B258) 2013; 110
De Gruijl (2023013012234150500_B100) 2006; 176
Greter (2023013012234150500_B91) 2012; 37
Espuelas (2023013012234150500_B220) 2008; 19
Sartorius (2023013012234150500_B143) 2011; 41
Schaefer (2023013012234150500_B227) 2008; 180
Han (2023013012234150500_B177) 2004; 104
Carter (2023013012234150500_B183) 2006; 177
Tacken (2023013012234150500_B12) 2007; 7
Geijtenbeek (2023013012234150500_B125) 2000; 100
Van Broekhoven (2023013012234150500_B144) 2004; 64
Pasetto (2023013012234150500_B277) 2016; 4
Engering (2023013012234150500_B223) 2002; 168
Apostolopoulos (2023013012234150500_B206) 2000; 18
Singh (2023013012234150500_B209) 2011; 41
Heidkamp (2023013012234150500_B73) 2016; 1
Kreutz (2023013012234150500_B149) 2012; 7
Pugholm (2023013012234150500_B168) 2015; 82
Karanikas (2023013012234150500_B262) 1997; 100
Li (2023013012234150500_B166) 2015; 45
Hawiger (2023013012234150500_B134) 2001; 194
Huysamen (2023013012234150500_B165) 2008; 283
Burgdorf (2023013012234150500_B199) 2008; 9
Karanikas (2023013012234150500_B263) 2001; 24
Guilliams (2023013012234150500_B36) 2016; 45
Tel (2023013012234150500_B9) 2013; 73
Chen (2023013012234150500_B259) 2012; 7
Hor (2023013012234150500_B65) 2015; 43
Kasahara (2023013012234150500_B180) 2012; 91
Santegoets (2023013012234150500_B111) 2008; 84
Fehres (2023013012234150500_B275) 2014; 44
Caminschi (2023013012234150500_B28) 2008; 112
Kanazawa (2023013012234150500_B129) 2002; 118
Demangel (2023013012234150500_B141) 2005; 42
Kretzer (2023013012234150500_B68) 2016; 213
Miller (2023013012234150500_B21) 2012; 13
Flacher (2023013012234150500_B196) 2014; 6
Yang (2023013012234150500_B235) 2008; 26
Leibundgut-Landmann (2023013012234150500_B190) 2008; 112
Crocker (2023013012234150500_B252) 1994; 13
Steinman (2023013012234150500_B11) 2007; 449
Van Vliet (2023013012234150500_B132) 2005; 17
Morse (2023013012234150500_B261) 2011; 10
Van de Ven (2023013012234150500_B8) 2011; 61
Mouriès (2023013012234150500_B51) 2008; 112
Cao (2023013012234150500_B142) 2013; 14
Fasting (2023013012234150500_B139) 2012; 51
Lee (2023013012234150500_B128) 2011; 21
Schumacher (2023013012234150500_B276) 2015; 348
Romano (2023013012234150500_B7) 2011; 17
Dorner (2023013012234150500_B25) 2009; 31
Galustian (2023013012234150500_B123) 2004; 16
Dud
References_xml – volume: 6
  start-page: 498
  year: 2013
  end-page: 510
  article-title: Resident and pro‐inflammatory macrophages in the colon represent alternative context‐dependent fates of the same Ly6Chi monocyte precursors
  publication-title: Mucosal Immunol.
– volume: 116
  start-page: 1685
  year: 2010
  end-page: 1697
  article-title: Cross‐priming CD8 T cells by targeting antigens to human dendritic cells through DCIR
  publication-title: Blood
– volume: 106
  start-page: 20377
  year: 2009
  end-page: 20381
  article-title: Different cross‐presentation pathways in steady‐state and inflammatory dendritic cells
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 192
  start-page: 1685
  year: 2000
  end-page: 1696
  article-title: CD8+ but not CD8 dendritic cells cross‐prime cytotoxic T cells in vivo
  publication-title: J. Exp. Med.
– volume: 194
  start-page: 769
  year: 2001
  end-page: 779
  article-title: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
  publication-title: J. Exp. Med.
– volume: 177
  start-page: 2276
  year: 2006
  end-page: 2284
  article-title: Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell‐associated C‐type lectin‐1
  publication-title: J. Immunol.
– volume: 44
  start-page: 2415
  year: 2014
  end-page: 2424
  article-title: Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T‐cell cross‐priming
  publication-title: Eur. J. Immunol.
– volume: 37
  start-page: 267
  year: 2014
  end-page: 277
  article-title: Ex vivo generation of interstitial and Langerhans cell‐like dendritic cell subset‐based vaccines for hematological malignancies
  publication-title: J. Immunother.
– volume: 13
  start-page: 1118
  year: 2012
  end-page: 1128
  article-title: Gene‐expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
  publication-title: Nat. Immunol.
– volume: 4
  start-page: 403
  year: 2013
  article-title: Dendritic cell plasticity in tumor‐conditioned skin: CD14 cells at the cross‐roads of immune activation and suppression
  publication-title: Front. Immunol.
– volume: 121
  start-page: 174
  year: 2007
  end-page: 182
  article-title: Lewis X oligosaccharides targeting to DC‐SIGN enhanced antigen‐specific immune response
  publication-title: Immunology
– volume: 10
  start-page: 733
  year: 2011
  end-page: 742
  article-title: CDX‐1307: a novel vaccine under study as treatment for muscle‐invasive bladder cancer
  publication-title: Expert Rev. Vaccines
– volume: 160
  start-page: 88
  year: 2012
  end-page: 95
  article-title: Glycan‐modified liposomes boost CD4+ and CD8+ T‐cell responses by targeting DC‐SIGN on dendritic cells
  publication-title: J. Control. Release
– volume: 14
  start-page: 39
  year: 2013
  article-title: DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
  publication-title: BMC Immunol.
– volume: 116
  start-page: 2277
  year: 2010
  end-page: 2285
  article-title: Targeting of DEC‐205 on human dendritic cells results in efficient MHC class II‐restricted antigen presentation
  publication-title: Blood
– volume: 35
  start-page: 541
  year: 2013
  end-page: 552
  article-title: Macrophage heterogeneity in lymphoid tissues
  publication-title: Semin. Immunopathol.
– volume: 22
  start-page: 2155
  year: 2016
  end-page: 2166
  article-title: Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells
  publication-title: Clin. Cancer Res.
– volume: 45
  start-page: 1205
  year: 2016
  end-page: 1218
  article-title: The heterogeneity of Ly6C monocytes controls their differentiation into iNOS macrophages or monocyte‐derived dendritic cells
  publication-title: Immunity
– volume: 156
  start-page: 128
  year: 1996
  end-page: 135
  article-title: Molecular cloning and expression of cDNA encoding human macrophage C‐type lectin. Its unique carbohydrate binding specificity for Tn antigen
  publication-title: J. Immunol.
– volume: 192
  start-page: 209
  year: 2014
  end-page: 218
  article-title: Targeting nanoparticles to CD40, DEC‐205 or CD11c molecules on dendritic cells for efficient CD8 T cell response: a comparative study
  publication-title: J. Control. Release
– volume: 204
  start-page: 3133
  year: 2007
  end-page: 3146
  article-title: Blood‐derived dermal langerin dendritic cells survey the skin in the steady state
  publication-title: J. Exp. Med.
– volume: 4
  start-page: 8
  year: 2016
  article-title: Direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies
  publication-title: Vaccines (Basel)
– volume: 180
  start-page: 6836
  year: 2008
  end-page: 6845
  article-title: Decreased pathology and prolonged survival of human DC‐SIGN transgenic mice during mycobacterial infection
  publication-title: J. Immunol.
– volume: 16
  start-page: 406
  year: 2015
  end-page: 414
  article-title: Proinflammatory microenvironments within the intestine regulate the differentiation of tissue‐resident CD8 T cells responding to infection
  publication-title: Nat. Immunol.
– volume: 11
  start-page: e0155189
  year: 2016
  article-title: Low mutation burden in ovarian cancer may limit the utility of neoantigen‐targeted vaccines
  publication-title: PLoS One
– volume: 107
  start-page: 1459
  year: 2006
  end-page: 1467
  article-title: Dendritic‐cell‐associated C‐type lectin 2 (DCAL‐2) alters dendritic‐cell maturation and cytokine production
  publication-title: Blood
– volume: 106
  start-page: 1278
  year: 2005
  end-page: 1285
  article-title: Effective induction of naive and recall T‐cell responses by targeting antigen to human dendritic cells via a humanized anti‐DC‐SIGN antibody
  publication-title: Blood
– volume: 458
  start-page: 899
  year: 2009
  end-page: 903
  article-title: Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
  publication-title: Nature
– volume: 34
  start-page: 9589
  year: 2016
  end-page: 9589
  publication-title: J. of Clin. Oncol
– volume: 41
  start-page: 98
  year: 2008
  end-page: 107
  article-title: Targeted cancer therapy: conferring specificity to cytotoxic drugs
  publication-title: Acc. Chem. Res.
– volume: 43
  start-page: 2543
  year: 2013
  end-page: 2553
  article-title: In vivo targeting of human DC‐SIGN drastically enhances CD8+ T‐cell‐mediated protective immunity
  publication-title: Eur. J. Immunol.
– volume: 15
  start-page: 471
  year: 2015
  end-page: 485
  article-title: The multifaceted biology of plasmacytoid dendritic cells
  publication-title: Nat. Rev. Immunol.
– volume: 10
  start-page: 1920
  year: 2004
  end-page: 1927
  article-title: A novel human cancer vaccine elicits cellular responses to the tumor‐associated antigen, human chorionic gonadotropin ß
  publication-title: Clin. Cancer Res.
– start-page: 4
  year: 2016
  article-title: Lectin receptors expressed on myeloid cells
  publication-title: Microbiol. Spectr.
– volume: 41
  start-page: 1014
  year: 2011
  end-page: 1023
  article-title: DEC‐205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells
  publication-title: Eur. J. Immunol.
– volume: 37
  start-page: 905
  year: 2012
  end-page: 916
  article-title: Two distinct types of Langerhans cells populate the skin during steady state and inflammation
  publication-title: Immunity
– volume: 176
  start-page: 4431
  year: 2006
  end-page: 4439
  article-title: The vast majority of CLA+ T cells are resident in normal skin
  publication-title: J. Immunol.
– volume: 207
  start-page: 1273
  year: 2010
  end-page: 1281
  article-title: Superior antigen cross‐presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
  publication-title: J. Exp. Med.
– volume: 365
  start-page: 127
  year: 2011
  end-page: 138
  article-title: IRF8 mutations and human dendritic‐cell immunodeficiency
  publication-title: N. Engl. J. Med.
– volume: 181
  start-page: 3148
  year: 2008
  end-page: 3155
  article-title: The C‐type lectin macrophage galactose‐type lectin impedes migration of immature APCs
  publication-title: J. Immunol.
– volume: 122
  start-page: 839
  year: 2008
  end-page: 846
  article-title: Glycan modification of the tumor antigen gp100 targets DC‐SIGN to enhance dendritic cell induced antigen presentation to T cells
  publication-title: Int. J. Cancer
– volume: 22
  start-page: 1897
  year: 2016
  end-page: 1906
  article-title: Dendritic cell‐based immunotherapy: state of the art and beyond
  publication-title: Clin. Cancer Res.
– volume: 168
  start-page: 2118
  year: 2002
  end-page: 2126
  article-title: The dendritic cell‐specific adhesion receptor DC‐SIGN internalizes antigen for presentation to T cells
  publication-title: J. Immunol.
– volume: 38
  start-page: 1157
  year: 2008
  end-page: 1163
  article-title: Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand
  publication-title: Eur. J. Immunol.
– volume: 515
  start-page: 568
  year: 2014
  end-page: 571
  article-title: PD‐1 blockade induces responses by inhibiting adaptive immune resistance
  publication-title: Nature
– volume: 73
  start-page: 1063
  year: 2013
  end-page: 1075
  article-title: Natural human plasmacytoid dendritic cells induce antigen‐specific T‐cell responses in melanoma patients
  publication-title: Cancer Res.
– volume: 112
  start-page: 3264
  year: 2008
  end-page: 3273
  article-title: The dendritic cell subtype‐restricted C‐type lectin Clec9A is a target for vaccine enhancement
  publication-title: Blood
– volume: 17
  start-page: 661
  year: 2005
  end-page: 669
  article-title: Carbohydrate profiling reveals a distinctive role for the C‐type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells
  publication-title: Int. Immunol.
– volume: 1253
  start-page: 149
  year: 2012
  end-page: 158
  article-title: An evolutionary perspective on C‐type lectins in infection and immunity
  publication-title: Ann. N. Y. Acad. Sci
– volume: 23
  start-page: 28
  year: 2016
  end-page: 35
  article-title: Langerhans cell origin and regulation
  publication-title: Curr. Opin. Hematol.
– volume: 13
  start-page: 753
  year: 2012
  end-page: 760
  article-title: IL‐34 is a tissue‐restricted ligand of CSF1R required for the development of Langerhans cells and microglia
  publication-title: Nat. Immunol.
– volume: 85
  start-page: 518
  year: 2008
  end-page: 525
  article-title: DCIR is endocytosed into human dendritic cells and inhibits TLR8‐mediated cytokine production
  publication-title: J. Leukoc. Biol.
– volume: 46
  start-page: 1240
  year: 2009
  end-page: 1249
  article-title: Characterization of murine MGL1 and MGL2 C‐type lectins: distinct glycan specificities and tumor binding properties
  publication-title: Mol. Immunol.
– volume: 8
  start-page: 824
  year: 2006
  end-page: 834
  article-title: Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration
  publication-title: J. Gene Med.
– volume: 15
  start-page: 2462
  year: 2016
  end-page: 2474
  article-title: Distinct transcriptional programs control cross‐priming in classical and monocyte‐derived dendritic cells
  publication-title: Cell Reports
– volume: 174
  start-page: 6592
  year: 2005
  end-page: 6597
  article-title: Cutting edge: generation of splenic CD8 and CD8 dendritic cell equivalents in Fms‐like tyrosine kinase 3 ligand bone marrow cultures
  publication-title: J. Immunol.
– volume: 213
  start-page: 2861
  year: 2016
  end-page: 2870
  article-title: Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c or CD141 DCs
  publication-title: J. Exp. Med.
– volume: 180
  start-page: 3647
  year: 2008
  end-page: 3650
  article-title: Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo
  publication-title: J. Immunol.
– volume: 180
  start-page: 4540
  year: 2008
  end-page: 4549
  article-title: Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model
  publication-title: J. Immunol.
– volume: 7
  start-page: 40437
  year: 2016
  end-page: 40450
  article-title: A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
  publication-title: Oncotarget
– volume: 45
  start-page: 747
  year: 2015
  end-page: 757
  article-title: Antigen targeting reveals splenic CD169 macrophages as promoters of germinal center B‐cell responses
  publication-title: Eur. J. Immunol.
– volume: 207
  start-page: 823
  year: 2010
  end-page: 836
  article-title: Peripheral CD103 dendritic cells form a unified subset developmentally related to CD8a+ conventional dendritic cells
  publication-title: J. Exp. Med.
– volume: 277
  start-page: 20686
  year: 2002
  end-page: 20693
  article-title: The macrophage C‐type lectin specific for galactose/N‐acetylgalactosamine is an endocytic receptor expressed on monocyte‐derived immature dendritic cells
  publication-title: J. Biol. Chem.
– volume: 38
  start-page: 322
  year: 2013
  end-page: 335
  article-title: Conventional and monocyte‐derived CD11b+ dendritic cells initiate and maintain T helper 2 cell‐mediated immunity to house dust mite allergen
  publication-title: Immunity
– volume: 3
  start-page: 48
  year: 2015
  end-page: 58
  article-title: High and interrelated rates of PD‐L1 CD14 antigen‐presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer
  publication-title: Cancer Immunol. Res.
– volume: 322
  start-page: 1097
  year: 2008
  end-page: 1100
  article-title: Batf3 deficiency reveals a critical role for CD8a+ dendritic cells in cytotoxic T cell immunity
  publication-title: Science
– volume: 131
  start-page: 641
  year: 2007
  end-page: 643
  article-title: Antigen presentation the macrophage way
  publication-title: Cell
– volume: 81
  start-page: 143
  year: 2017
  end-page: 150
  article-title: Antibody‐mediated targeting of antigen to C‐type lectin‐like receptors Clec9A and Clec12A elicits different vaccination outcomes
  publication-title: Mol. Immunol.
– volume: 64
  start-page: 4357
  year: 2004
  end-page: 4365
  article-title: Targeting dendritic cells with antigen‐containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
  publication-title: Cancer Res.
– volume: 324
  start-page: 392
  year: 2009
  end-page: 397
  article-title: In vivo analysis of dendritic cell development and homeostasis
  publication-title: Science
– volume: 53
  start-page: 1387
  year: 2010
  end-page: 1391
  article-title: Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization
  publication-title: J. Med. Chem.
– volume: 176
  start-page: 426
  year: 2006
  end-page: 440
  article-title: Internalizing antibodies to the C‐type lectins, L‐SIGN and DC‐SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses
  publication-title: J. Immunol.
– volume: 28
  start-page: 2288
  year: 2011
  end-page: 2301
  article-title: Activation of antigen‐specific T cell‐responses by mannan‐decorated PLGA nanoparticles
  publication-title: Pharm. Res.
– volume: 37
  start-page: 1076
  year: 2012
  end-page: 1090
  article-title: Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen‐presenting cells
  publication-title: Immunity
– volume: 43
  start-page: 554
  year: 2015
  end-page: 565
  article-title: Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4 and CD8 T cell activation to localized viral infection
  publication-title: Immunity
– volume: 77
  start-page: 85
  year: 2015
  end-page: 92
  article-title: Human skin dendritic cells in health and disease
  publication-title: J. Dermatol. Sci.
– volume: 176
  start-page: 7232
  year: 2006
  end-page: 7242
  article-title: A postmigrational switch among skin‐derived dendritic cells to a macrophage‐like phenotype is predetermined by the intracutaneous cytokine balance
  publication-title: J. Immunol.
– volume: 135
  start-page: 2228
  year: 2015
  end-page: 2236
  article-title: In situ delivery of sntigen to DC‐SIGN+ CD14+ dermal dendritic cells results in enhanced CD8+ T‐cell responses
  publication-title: J. Invest. Dermatol.
– volume: 9
  start-page: 250
  year: 2013
  end-page: 256
  article-title: Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells
  publication-title: Nat. Chem. Biol.
– volume: 18
  start-page: 1547
  year: 2007
  end-page: 1554
  article-title: Synthesis of glycocluster‐tumor antigenic peptide conjugates for dendritic cell targeting
  publication-title: Bioconjug. Chem.
– volume: 9
  start-page: e103755
  year: 2014
  article-title: Enhanced cross‐presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice
  publication-title: PLoS One
– volume: 91
  start-page: 437
  year: 2012
  end-page: 448
  article-title: Dendritic cell‐associated lectin 2 (DCAL2) defines a distinct CD8α‐ dendritic cell subset
  publication-title: J. Leukoc. Biol.
– volume: 113
  start-page: E7759
  year: 2016
  end-page: E7768
  article-title: Density of immunogenic antigens does not explain the presence or absence of the T‐cell–inflamed tumor microenvironment in melanoma
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 45
  start-page: 854
  year: 2015
  end-page: 864
  article-title: Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non‐human primates
  publication-title: Eur. J. Immunol.
– volume: 29
  start-page: 497
  year: 2008
  end-page: 510
  article-title: Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells
  publication-title: Immunity
– volume: 107
  start-page: 216
  year: 2010
  end-page: 221
  article-title: Effective collaboration between marginal metallophilic macrophages and CD8 dendritic cells in the generation of cytotoxic T cells
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 29
  start-page: 4813
  year: 2011
  end-page: 4820
  article-title: Delivery of antigen to sialoadhesin or CD163 improves the specific immune response in pigs
  publication-title: Vaccine
– volume: 185
  start-page: 3504
  year: 2010
  end-page: 3513
  article-title: Concomitant activation and antigen uptake via human Dectin‐1 results in potent antigen‐specific CD8+ T cell responses
  publication-title: J. Immunol.
– volume: 206
  start-page: 3089
  year: 2009
  end-page: 3100
  article-title: Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation‐associated expansion of the epidermal LC network
  publication-title: J. Exp. Med.
– volume: 182
  start-page: 7587
  year: 2009
  end-page: 7594
  article-title: The C‐type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses
  publication-title: J. Immunol.
– volume: 274
  start-page: 19087
  year: 1999
  end-page: 19094
  article-title: Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells
  publication-title: J. Biol. Chem.
– volume: 351
  start-page: 181
  year: 2012
  end-page: 220
  article-title: The dermis as a portal for dendritic cell‐targeted immunotherapy of cutaneous melanoma
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 36
  start-page: 635
  year: 2012
  end-page: 645
  article-title: F‐actin is an evolutionarilyconserved damage‐associated molecular pattern recognized by DNGR‐1, a receptor for dead cells
  publication-title: Immunity
– volume: 17
  start-page: 1984
  year: 2011
  end-page: 1997
  article-title: Peptide‐loaded Langerhans cells, despite increased IL15 secretion and T‐cell activation in vitro, elicit antitumor T‐cell responses comparable to peptide‐loaded monocyte‐derived dendritic cells in vivo
  publication-title: Clin. Cancer Res.
– volume: 7
  start-page: e2330
  year: 2013
  article-title: Targeting the non‐structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
  publication-title: PLoS Negl. Trop. Dis.
– volume: 21
  start-page: 81
  year: 2015
  end-page: 85
  article-title: High‐throughput epitope discovery reveals frequent recognition of neo‐antigens by CD4+ T cells in human melanoma
  publication-title: Nat. Med.
– volume: 119
  start-page: 6052
  year: 2012
  end-page: 6062
  article-title: DNGR‐1 is a specific and universal marker of mouse and human Batf3‐dependent dendritic cells in lymphoid and nonlymphoid tissues
  publication-title: Blood
– volume: 181
  start-page: 2455
  year: 2008
  end-page: 2464
  article-title: The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells
  publication-title: J. Immunol.
– volume: 7
  start-page: e39039
  year: 2012
  article-title: Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169
  publication-title: PLoS One
– volume: 118
  start-page: 2502
  year: 2011
  end-page: 2510
  article-title: Characterization of four conventional dendritic cell subsets in human skin‐draining lymph nodes in relation to T‐cell activation
  publication-title: Blood
– volume: 13
  start-page: 2961
  year: 2007
  end-page: 2969
  article-title: Intradermal CpG‐B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients
  publication-title: Clin. Cancer Res.
– volume: 42
  start-page: 916
  year: 2015
  end-page: 928
  article-title: Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses
  publication-title: Immunity
– volume: 44
  start-page: 924
  year: 2016
  end-page: 938
  article-title: Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD‐L1 and BRAF inhibition
  publication-title: Immunity
– volume: 111
  start-page: 1942
  year: 2008
  end-page: 1945
  article-title: The mutation in IRF8 differentially impairs dendritic cell subset development in the mouse
  publication-title: Blood
– volume: 10
  start-page: 1661
  year: 1991
  end-page: 1669
  article-title: Purification and properties of sialoadhesin, a sialic acid‐binding receptor of murine tissue macrophages
  publication-title: EMBO J.
– volume: 22
  start-page: 33
  year: 2004
  end-page: 54
  article-title: Self‐ and nonself‐recognition by C‐type lectins on dendritic cells
  publication-title: Annu. Rev. Immunol.
– volume: 31
  start-page: 502
  year: 2009
  end-page: 512
  article-title: Intestinal lamina propria dendritic cell subsets have different origin and functions
  publication-title: Immunity
– volume: 7
  start-page: e40208
  year: 2012
  article-title: Antibody‐antigen‐adjuvant conjugates enable co‐delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity
  publication-title: PLoS One
– volume: 315
  start-page: 107
  year: 2007
  end-page: 111
  article-title: Differential antigen processing by dendritic cell subsets in vivo
  publication-title: Science
– volume: 51
  start-page: 10472
  year: 2012
  end-page: 10498
  article-title: Multivalency as a chemical organization and action principle
  publication-title: Angew. Chem. Int. Ed. Engl.
– volume: 39
  start-page: 733
  year: 2013
  end-page: 743
  article-title: CD301b+ dermal dendritic cells drive T helper 2 cell‐mediated immunity
  publication-title: Immunity
– volume: 9
  start-page: 676
  year: 2008
  end-page: 683
  article-title: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues
  publication-title: Nat. Immunol.
– volume: 192
  start-page: 5830
  year: 2014
  end-page: 5838
  article-title: Antigen delivery to CD11 8 dendritic cells induces protective immune responses against experimental melanoma in mice in vivo
  publication-title: J. Immunol.
– volume: 9
  start-page: 679
  year: 2009
  end-page: 691
  article-title: Skin immune sentinels in health and disease
  publication-title: Nat. Rev. Immunol.
– volume: 41
  start-page: 465
  year: 2014
  end-page: 477
  article-title: Human dermal CD14+ cells are a transient population of monocyte‐derived macrophages
  publication-title: Immunity
– volume: 162
  start-page: 1322
  year: 2015
  end-page: 1337
  article-title: Robust anti‐viral immunity requires multiple distinct T cell‐dendritic cell interactions
  publication-title: Cell
– volume: 186
  start-page: 1218
  year: 2011
  end-page: 1227
  article-title: Antibody‐targeted NY‐ESO‐1 to mannose receptor or DEC‐205 in vitro elicits dual human CD8 and CD4 T cell responses with broad antigen specificity
  publication-title: J. Immunol.
– volume: 199
  start-page: 815
  year: 2004
  end-page: 824
  article-title: In vivo targeting of antigens to maturing dendritic cells via the DEC‐205 receptor improves T cell vaccination
  publication-title: J. Exp. Med.
– volume: 82
  start-page: 515
  year: 2015
  end-page: 522
  article-title: Enhanced humoral responses induced by targeting of antigen to murine dendritic cells
  publication-title: Scand. J. Immunol.
– volume: 196
  start-page: 1415
  year: 2002
  end-page: 1425
  article-title: ICSBP is essential for the development of mouse type I interferon‐producing cells and for the generation and activation of CD8a+ dendritic cells
  publication-title: J. Exp. Med.
– volume: 21
  start-page: 512
  year: 2011
  end-page: 520
  article-title: Survey of immune‐related, mannose/fucose‐binding C‐type lectin receptors reveals widely divergent sugar‐binding specificities
  publication-title: Glycobiology
– volume: 17
  start-page: 4844
  year: 2011
  end-page: 4853
  article-title: Phase I study utilizing a novel antigen‐presenting cell‐targeted vaccine with Toll‐like receptor stimulation to induce immunity to self‐antigens in cancer patients
  publication-title: Clin. Cancer Res.
– volume: 193
  start-page: 2297
  year: 2014
  end-page: 2305
  article-title: Nanoparticle‐mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL‐15‐dependent DC crosstalk
  publication-title: J. Immunol.
– volume: 190
  start-page: 4116
  year: 2013
  end-page: 4128
  article-title: Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin‐1 by incorporating ß‐glucan
  publication-title: J. Immunol.
– volume: 4
  start-page: 734
  year: 2016
  end-page: 743
  article-title: Tumor‐ and neoantigen‐reactive T‐cell receptors can be identified based on their frequency in fresh tumor
  publication-title: Cancer Immunol. Res.
– volume: 13
  start-page: 401
  year: 2003
  end-page: 410
  article-title: Characterization of carbohydrate recognition by langerin, a C‐type lectin of Langerhans cells
  publication-title: Glycobiology
– volume: 23
  start-page: 909
  year: 2014
  end-page: 915
  article-title: Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors
  publication-title: Exp. Dermatol.
– volume: 34
  start-page: 440
  year: 2013
  end-page: 445
  article-title: Inflammatory dendritic cells in mice and humans
  publication-title: Trends Immunol.
– volume: 348
  start-page: 69
  year: 2015
  end-page: 74
  article-title: Neoantigens in cancer immunotherapy
  publication-title: Science
– volume: 31
  start-page: 513
  year: 2009
  end-page: 525
  article-title: Origin of the lamina propria dendritic cell network
  publication-title: Immunity
– volume: 5
  start-page: 5
  year: 2007
  article-title: Toll‐like receptor activation enhances cell‐mediated immunity induced by an antibody vaccine targeting human dendritic cells
  publication-title: J. Transl. Med.
– volume: 32
  start-page: 4574
  year: 2011
  end-page: 4583
  article-title: Antitumor activity of liposomal ErbB2/HER2 epitope peptide‐based vaccine constructs incorporating TLR agonists and mannose receptor targeting
  publication-title: Biomaterials
– volume: 190
  start-page: 3338
  year: 2013
  end-page: 3345
  article-title: Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic‐polyribocytidylic acid and peptidoglycans
  publication-title: J. Immunol.
– volume: 211
  start-page: 651
  year: 2006
  end-page: 661
  article-title: Immunomodulation of the melanoma sentinel lymph node: a novel adjuvant therapeutic option
  publication-title: Immunobiology
– volume: 111
  start-page: 4245
  year: 2008
  end-page: 4253
  article-title: Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN‐a production
  publication-title: Blood
– volume: 3
  start-page: e21
  year: 2014
  article-title: Dendritic cell immunotherapy: clinical outcomes
  publication-title: Clin. Transl. Immunology
– volume: 45
  start-page: 669
  year: 2016
  end-page: 684
  article-title: Unsupervised high‐dimensional analysis aligns dendritic cells across tissues and species
  publication-title: Immunity
– volume: 35
  start-page: 469
  year: 2017
  end-page: 499
  article-title: Antigen‐presenting cells in the skin
  publication-title: Annu. Rev. Immunol.
– volume: 187
  start-page: 842
  year: 2011
  end-page: 850
  article-title: Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype
  publication-title: J. Immunol.
– volume: 172
  start-page: 2845
  year: 2004
  end-page: 2852
  article-title: Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti‐melanoma T cell responses via multiple HLA molecules
  publication-title: J. Immunol.
– volume: 449
  start-page: 419
  year: 2007
  end-page: 426
  article-title: Taking dendritic cells into medicine
  publication-title: Nature
– volume: 3
  start-page: 495
  year: 2015
  end-page: 505
  article-title: Arming the melanoma sentinel lymph node through local administration of CpG‐B and GM‐CSF: recruitment and activation of BDCA3/CD141 dendritic cells and enhanced cross‐presentation
  publication-title: Cancer Immunol. Res.
– volume: 37
  start-page: 2075
  year: 2007
  end-page: 2081
  article-title: MGL‐mediated internalization and antigen presentation by dendritic cells: a role for tyrosine‐5
  publication-title: Eur. J. Immunol.
– volume: 101
  start-page: 305
  year: 2003
  end-page: 310
  article-title: Essential role for ICSBP in the in vivo development of murine CD8a + dendritic cells
  publication-title: Blood
– volume: 61
  start-page: 181
  year: 2011
  end-page: 191
  article-title: Exposure of CD34+ precursors to cytostatic anthraquinone‐derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy
  publication-title: Cancer Immunol. Immunother.
– volume: 17
  start-page: 211
  year: 2002
  end-page: 220
  article-title: In vivo depletion of CD11c dendritic cells abrogates priming of CD8 T cells by exogenous cell‐associated antigens
  publication-title: Immunity
– volume: 33
  start-page: 4229
  year: 2012
  end-page: 4239
  article-title: Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC‐SIGN
  publication-title: Biomaterials
– volume: 209
  start-page: 1167
  year: 2012
  end-page: 1181
  article-title: Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac‐derived macrophages
  publication-title: J. Exp. Med.
– volume: 119
  start-page: 2284
  year: 2012
  end-page: 2292
  article-title: The C‐type lectin receptor CLEC9A mediates antigen uptake and (cross‐)presentation by human blood BDCA3+ myeloid dendritic cells
  publication-title: Blood
– volume: 167
  start-page: 1301
  year: 2005
  end-page: 1307
  article-title: Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells
  publication-title: Am. J. Pathol.
– volume: 14
  start-page: 360
  year: 2017
  end-page: 370
  article-title: Langerin‐mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross‐presentation by human Langerhans cells
  publication-title: Cell. Mol. Immunol.
– volume: 128
  start-page: 1371
  year: 2011
  end-page: 1383
  article-title: Tumour‐associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses
  publication-title: Int. J. Cancer
– volume: 4
  start-page: 1953
  year: 2004
  end-page: 1962
  article-title: Mannose receptor‐targeted vaccines
  publication-title: Expert Opin. Biol. Ther.
– volume: 209
  start-page: 653
  year: 2012
  end-page: 660
  article-title: Characterization of resident and migratory dendritic cells in human lymph nodes
  publication-title: J. Exp. Med.
– volume: 67
  start-page: 8358
  year: 2007
  end-page: 8367
  article-title: Tumor‐associated Tn‐MUC1 glycoform is internalized through the macrophage galactose‐type C‐type lectin and delivered to the HLA class I and II compartments in dendritic cells
  publication-title: Cancer Res.
– start-page: 115
  year: 2009
  end-page: 128
– volume: 4
  start-page: e970462
  year: 2014
  article-title: Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long‐term tumor regression
  publication-title: OncoImmunology
– volume: 34
  start-page: 4857
  year: 2016
  end-page: 4865
  article-title: Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes
  publication-title: Vaccine
– volume: 16
  start-page: 853
  year: 2004
  end-page: 866
  article-title: High and low affinity carbohydrate ligands revealed for murine SIGN‐R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN‐R3 and langerin
  publication-title: Int. Immunol.
– volume: 13
  start-page: 888
  year: 2012
  end-page: 899
  article-title: Deciphering the transcriptional network of the dendritic cell lineage
  publication-title: Nat. Immunol.
– volume: 14
  start-page: 417
  year: 2014
  end-page: 428
  article-title: The origins and functions of dendritic cells and macrophages in the skin
  publication-title: Nat. Rev. Immunol.
– volume: 38
  start-page: 2389
  year: 2008
  end-page: 2400
  article-title: Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix‐loop‐helix factor E2‐2 and the Ets factor Spi‐B
  publication-title: Eur. J. Immunol.
– volume: 100
  start-page: 575
  year: 2000
  end-page: 585
  article-title: Identification of DC‐SIGN, a novel dendritic cell‐specific ICAM‐3 receptor that supports primary immune responses
  publication-title: Cell
– volume: 168
  start-page: 782
  year: 2002
  end-page: 792
  article-title: Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues
  publication-title: J. Immunol.
– volume: 30
  start-page: 705
  year: 2007
  end-page: 714
  article-title: In vivo targeting of DC‐SIGN‐positive antigen‐presenting cells in a nonhuman primate model
  publication-title: J. Immunother.
– volume: 193
  start-page: 961
  year: 2014
  end-page: 969
  article-title: Targeted delivery of a‐galactosylceramide to CD8a+ dendritic cells optimizes type I NKT cell‐based antitumor responses
  publication-title: J. Immunol.
– volume: 104
  start-page: 2858
  year: 2004
  end-page: 2866
  article-title: KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity
  publication-title: Blood
– volume: 346
  start-page: 93
  year: 2014
  end-page: 98
  article-title: T cell memory. A local macrophage chemokine network sustains protective tissue‐resident memory CD4 T cells
  publication-title: Science
– volume: 119
  start-page: 5182
  year: 2012
  end-page: 5190
  article-title: Human Langerhans cells use an IL‐15R‐a/IL‐15/pSTAT5‐dependent mechanism to break T‐cell tolerance against the self‐differentiation tumor antigen WT1
  publication-title: Blood
– volume: 129
  start-page: 26
  year: 2008
  end-page: 32
  article-title: Oligomannose‐coated liposomes as a therapeutic antigen‐delivery and an adjuvant vehicle for induction of in vivo tumor immunity
  publication-title: J. Control. Release
– volume: 203
  start-page: 67
  year: 2015
  end-page: 76
  article-title: Cross‐presentation through langerin and DC‐SIGN targeting requires different formulations of glycan‐modified antigens
  publication-title: J. Control. Release
– volume: 212
  start-page: 743
  year: 2015
  end-page: 757
  article-title: Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross‐priming dendritic cells
  publication-title: J. Exp. Med.
– volume: 7
  start-page: 255
  year: 2007
  end-page: 266
  article-title: Siglecs and their roles in the immune system
  publication-title: Nat. Rev. Immunol.
– volume: 112
  start-page: 3713
  year: 2008
  end-page: 3722
  article-title: Plasmacytoid dendritic cells efficiently cross‐prime naive T cells in vivo after TLR activation
  publication-title: Blood
– volume: 1
  start-page: eaai7677
  year: 2016
  article-title: Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment
  publication-title: Sci. Immunol.
– volume: 1
  start-page: e87102
  year: 2016
  article-title: Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
  publication-title: JCI Insight
– volume: 143
  start-page: 416
  year: 2010
  end-page: 429
  article-title: Microbial stimulation fully differentiates monocytes to DC‐SIGN/CD209+ dendritic cells for immune T cell areas
  publication-title: Cell
– volume: 3
  start-page: e28836
  year: 2014
  article-title: High sensitivity of cancer exome‐based CD8 T cell neo‐antigen identification
  publication-title: OncoImmunology
– volume: 391
  start-page: 958
  year: 2010
  end-page: 962
  article-title: Laminarin‐mediated targeting to Dectin‐1 enhances antigen‐specific immune responses
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 196
  start-page: 1627
  year: 2002
  end-page: 1638
  article-title: Efficient targeting of protein antigen to the dendritic cell receptor DEC‐205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
  publication-title: J. Exp. Med.
– volume: 84
  start-page: 143
  year: 2008
  end-page: 151
  article-title: Transcriptional profiling of human skin‐resident Langerhans cells and CD1a dermal dendritic cells: differential activation states suggest distinct functions
  publication-title: J. Leukoc. Biol.
– volume: 118
  start-page: 4111
  year: 2011
  end-page: 4119
  article-title: Targeting DC‐SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross‐presentation
  publication-title: Blood
– volume: 34
  start-page: 93
  year: 2016
  end-page: 119
  article-title: Transcriptional control of dendritic cell development
  publication-title: Annu. Rev. Immunol.
– volume: 12
  start-page: 2826
  year: 2006
  end-page: 2833
  article-title: Tumor‐specific CD8 T cell reactivity in the sentinel lymph node of GM‐CSF‐treated stage I melanoma patients is associated with high myeloid dendritic cell content
  publication-title: Clin. Cancer Res.
– volume: 158
  start-page: 73
  year: 2014
  end-page: 78
  article-title: Cross‐presentation by human dendritic cell subsets
  publication-title: Immunol. Lett.
– volume: 18
  start-page: 857
  year: 2006
  end-page: 869
  article-title: Expression of human DEC‐205 (CD205) multilectin receptor on leukocytes
  publication-title: Int. Immunol.
– volume: 8
  start-page: 578
  year: 2007
  end-page: 583
  article-title: Origin of dendritic cells in peripheral lymphoid organs of mice
  publication-title: Nat. Immunol.
– volume: 163
  start-page: 1973
  year: 1999
  end-page: 1983
  article-title: APCs express DCIR, a novel C‐type lectin surface receptor containing an immunoreceptor tyrosine‐based inhibitory motif
  publication-title: J. Immunol.
– volume: 135
  start-page: 37
  year: 2008
  end-page: 48
  article-title: Transcription factor E2‐2 is an essential and specific regulator of plasmacytoid dendritic cell development
  publication-title: Cell
– volume: 22
  start-page: 1903
  year: 2004
  end-page: 1913
  article-title: Interaction of dendritic cells with antigen‐containing liposomes: effect of bilayer composition
  publication-title: Vaccine
– volume: 38
  start-page: 970
  year: 2013
  end-page: 983
  article-title: IRF4 transcription factor‐dependent CD11b+ dendritic cells in human and mouse control mucosal IL‐17 cytokine responses
  publication-title: Immunity
– volume: 20
  start-page: 145
  year: 2011
  end-page: 146
  article-title: Self‐renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft
  publication-title: Exp. Dermatol.
– volume: 127
  start-page: 1
  year: 2015
  end-page: 31
  article-title: Cross‐presentation in mouse and human dendritic cells
  publication-title: Adv. Immunol.
– volume: 41
  start-page: 2573
  year: 2011
  end-page: 2584
  article-title: Vaccination with filamentous bacteriophages targeting DEC‐205 induces DC maturation and potent anti‐tumor T‐cell responses in the absence of adjuvants
  publication-title: Eur. J. Immunol.
– volume: 207
  start-page: 1261
  year: 2010
  end-page: 1271
  article-title: Characterization of human DNGR‐1 BDCA3 leukocytes as putative equivalents of mouse CD8α dendritic cells
  publication-title: J. Exp. Med.
– volume: 116
  start-page: 3828
  year: 2010
  end-page: 3838
  article-title: Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti‐human DEC205 monoclonal antibody
  publication-title: Blood
– volume: 26
  start-page: 638
  year: 2014
  end-page: 652
  article-title: Dissecting the tumor myeloid compartment reveals rare activating antigen‐presenting cells critical for T cell immunity
  publication-title: Cancer Cell
– volume: 118
  start-page: 2098
  year: 2008
  end-page: 2110
  article-title: Tumor therapy in mice via antigen targeting to a novel, DC‐restricted C‐type lectin
  publication-title: J. Clin. Invest.
– volume: 95
  start-page: 3489
  year: 2000
  end-page: 3497
  article-title: Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
  publication-title: Blood
– volume: 7
  start-page: 790
  year: 2007
  end-page: 802
  article-title: Dendritic‐cell immunotherapy: from ex vivo loading to in vivo targeting
  publication-title: Nat. Rev. Immunol.
– volume: 15
  start-page: 929
  year: 2014
  end-page: 937
  article-title: Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
  publication-title: Nat. Immunol.
– volume: 40
  start-page: 14
  year: 2009
  article-title: Targeting to porcine sialoadhesin receptor improves antigen presentation to T cells
  publication-title: Vet. Res.
– volume: 42
  start-page: 3150
  year: 2012
  end-page: 3166
  article-title: CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1‐inducing role of mesenteric lymph node macrophages during colitis
  publication-title: Eur. J. Immunol.
– volume: 210
  start-page: 1035
  year: 2013
  end-page: 1047
  article-title: Similar antigen cross‐presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ‐resident dendritic cells
  publication-title: J. Exp. Med.
– volume: 130
  start-page: 755
  year: 2010
  end-page: 762
  article-title: Epidermal Langerhans cells rapidly capture and present antigens from C‐type lectin‐targeting antibodies deposited in the dermis
  publication-title: J. Invest. Dermatol.
– volume: 97
  start-page: 627
  year: 2015
  end-page: 634
  article-title: langerin‐expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells
  publication-title: J. Leukoc. Biol.
– volume: 7
  start-page: 1200
  year: 2006
  end-page: 1208
  article-title: Regulation of effector T cells by antigen‐presenting cells via interaction of the C‐type lectin MGL with CD45
  publication-title: Nat. Immunol.
– volume: 209
  start-page: 1825
  year: 2012
  end-page: 1840
  article-title: Extrafollicular B cell activation by marginal zone dendritic cells drives T cell‐dependent antibody responses
  publication-title: J. Exp. Med.
– volume: 5
  start-page: 16
  year: 2017
  article-title: Combination immunotherapy: a road map
  publication-title: J. Immunother. Cancer
– volume: 279
  start-page: 14792
  year: 2004
  end-page: 14802
  article-title: Identification and characterization of a novel human myeloid inhibitory C‐type lectin‐like receptor (MICL) that is predominantly expressed on granulocytes and monocytes
  publication-title: J. Biol. Chem.
– volume: 38
  start-page: 424
  year: 2008
  end-page: 436
  article-title: Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo
  publication-title: Eur. J. Immunol.
– volume: 46
  start-page: S77
  year: 2000
  end-page: S82
  article-title: Development of a cancer vaccine: peptides, proteins, and DNA
  publication-title: Cancer Chemother. Pharmacol.
– volume: 92
  start-page: 1177
  year: 2012
  end-page: 1186
  article-title: The mannose receptor
  publication-title: J. Leukoc. Biol.
– volume: 122
  start-page: 1615
  year: 2012
  end-page: 1627
  article-title: The dendritic cell receptor DNGR‐1 controls endocytic handling of necrotic cell antigens to favor cross‐priming of CTLs in virus‐infected mice
  publication-title: J. Clin. Invest.
– volume: 184
  start-page: 1953
  year: 1996
  end-page: 1962
  article-title: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand‐treated mice: multiple dendritic cell subpopulations identified
  publication-title: J. Exp. Med.
– volume: 432
  start-page: 35
  year: 2016
  end-page: 49
  article-title: Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue‐resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells
  publication-title: J. Immunol. Methods
– volume: 8
  start-page: e52875
  year: 2013
  article-title: Transcriptional profiling of human dendritic cell populations and models—unique profiles of in vitro dendritic cells and implications on functionality and applicability
  publication-title: PLoS One
– volume: 19
  start-page: 2385
  year: 2008
  end-page: 2393
  article-title: Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes
  publication-title: Bioconjug. Chem.
– volume: 41
  start-page: 916
  year: 2011
  end-page: 925
  article-title: Design of neo‐glycoconjugates that target the mannose receptor and enhance TLR‐independent cross‐presentation and Th1 polarization
  publication-title: Eur. J. Immunol.
– volume: 30
  start-page: 715
  year: 2007
  end-page: 726
  article-title: In vivo targeting of antigens to human dendritic cells through DC‐SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models
  publication-title: J. Immunother.
– volume: 26
  start-page: 326
  year: 2008
  end-page: 334
  article-title: Engineered lentivector targeting of dendritic cells for in vivo immunization
  publication-title: Nat. Biotechnol.
– volume: 6
  start-page: 534
  year: 2015
  article-title: Functional specialization of skin dendritic cell subsets in regulating T cell responses
  publication-title: Front. Immunol.
– volume: 191
  start-page: 5005
  year: 2013
  end-page: 5012
  article-title: Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross‐presentation and robust type I IFN secretion
  publication-title: J. Immunol.
– volume: 118
  start-page: 261
  year: 2002
  end-page: 266
  article-title: DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine‐based inhibitory motif
  publication-title: J. Invest. Dermatol.
– volume: 9
  start-page: 558
  year: 2008
  end-page: 566
  article-title: Spatial and mechanistic separation of cross‐presentation and endogenous antigen presentation
  publication-title: Nat. Immunol.
– volume: 34
  start-page: 85
  year: 2011
  end-page: 95
  article-title: CD169‐positive macrophages dominate antitumor immunity by crosspresenting dead cell‐associated antigens
  publication-title: Immunity
– volume: 37
  start-page: 1050
  year: 2012
  end-page: 1060
  article-title: Stroma‐derived interleukin‐34 controls the development and maintenance of langerhans cells and the maintenance of microglia
  publication-title: Immunity
– volume: 16
  start-page: 718
  year: 2015
  end-page: 728
  article-title: Identification of cDC1‐ and cDC2‐committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
  publication-title: Nat. Immunol.
– volume: 37
  start-page: 60
  year: 2012
  end-page: 73
  article-title: Human tissues contain CD141 cross‐presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells
  publication-title: Immunity
– volume: 42
  start-page: 936
  year: 2012
  end-page: 945
  article-title: Targeting of macrophage galactose‐type C‐type lectin (MGL) induces DC signaling and activation
  publication-title: Eur. J. Immunol.
– volume: 121
  start-page: 5034
  year: 2013
  end-page: 5044
  article-title: CD141+ dendritic cells produce prominent amounts of IFN‐a after dsRNA recognition and can be targeted via DEC‐205 in humanized mice
  publication-title: Blood
– volume: 18
  start-page: 3174
  year: 2000
  end-page: 3184
  article-title: Ex vivo targeting of the macrophage mannose receptor generates anti‐tumor CTL responses
  publication-title: Vaccine
– volume: 6
  start-page: e16827
  year: 2011
  article-title: Porcine sialoadhesin (CD169/Siglec‐1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages
  publication-title: PLoS One
– volume: 39
  start-page: 925
  year: 2013
  end-page: 938
  article-title: Origins and functional specialization of macrophages and of conventional and monocyte‐derived dendritic cells in mouse skin
  publication-title: Immunity
– volume: 14
  start-page: 930
  year: 1996
  end-page: 938
  article-title: Cell‐mediated immune responses to MUC1 fusion protein coupled to mannan
  publication-title: Vaccine
– volume: 116
  start-page: 3526
  year: 2010
  end-page: 3536
  article-title: Glycosidic Tn‐based vaccines targeting dermal dendritic cells favor germinal center B‐cell development and potent antibody response in the absence of adjuvant
  publication-title: Blood
– volume: 5
  start-page: 606
  year: 2005
  end-page: 616
  article-title: Structure and function of the spleen
  publication-title: Nat. Rev. Immunol.
– volume: 44
  start-page: 1947
  year: 2014
  end-page: 1955
  article-title: Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
  publication-title: Eur. J. Immunol.
– volume: 316
  start-page: 612
  year: 2007
  end-page: 616
  article-title: Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
  publication-title: Science
– volume: 2
  start-page: e00757
  year: 2013
  article-title: EBI2‐mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture
  publication-title: eLife
– volume: 4
  start-page: 157
  year: 2013
  article-title: Skin‐resident antigen‐presenting cells: instruction manual for vaccine development
  publication-title: Front. Immunol.
– volume: 64
  start-page: 8456
  year: 2004
  end-page: 8460
  article-title: Local administration of granulocyte/macrophage colony‐stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early‐stage melanoma
  publication-title: Cancer Res.
– volume: 65
  start-page: 405
  year: 2016
  end-page: 415
  article-title: Local delivery of CpG‐B and GM‐CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node
  publication-title: Cancer Immunol. Immunother.
– volume: 14
  start-page: 571
  year: 2014
  end-page: 578
  article-title: Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
  publication-title: Nat. Rev. Immunol.
– volume: 112
  start-page: 5461
  year: 2015
  end-page: 5466
  article-title: CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross‐priming dendritic cells
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 42
  start-page: 101
  year: 2012
  end-page: 109
  article-title: A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
  publication-title: Eur. J. Immunol.
– volume: 31
  start-page: 823
  year: 2009
  end-page: 833
  article-title: Selective expression of the chemokine receptor XCR1 on cross‐presenting dendritic cells determines cooperation with CD8+ T cells
  publication-title: Immunity
– volume: 283
  start-page: 16693
  year: 2008
  end-page: 16701
  article-title: CLEC9A is a novel activation C‐type lectin‐like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes
  publication-title: J. Biol. Chem.
– volume: 12
  start-page: 71
  year: 2000
  end-page: 81
  article-title: langerin, a novel C‐type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules
  publication-title: Immunity
– volume: 13
  start-page: 4490
  year: 1994
  end-page: 4503
  article-title: Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin‐like domains
  publication-title: EMBO J.
– volume: 106
  start-page: 1659
  year: 2015
  end-page: 1668
  article-title: Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity
  publication-title: Cancer Sci.
– volume: 110
  start-page: 7826
  year: 2013
  end-page: 7831
  article-title: Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 100
  start-page: 2783
  year: 1997
  end-page: 2792
  article-title: Antibody and T cell responses of patients with adenocarcinoma immunized with mannan‐MUC1 fusion protein
  publication-title: J. Clin. Invest.
– volume: 38
  start-page: 41
  year: 2015
  end-page: 53
  article-title: Virological and preclinical characterization of a dendritic cell targeting, integration‐deficient lentiviral vector for cancer immunotherapy
  publication-title: J. Immunother.
– volume: 14
  start-page: 986
  year: 2013
  end-page: 995
  article-title: Tissue‐resident macrophages
  publication-title: Nat. Immunol.
– volume: 34
  start-page: 2847
  year: 2016
  end-page: 2854
  article-title: A phase 1a, first‐in‐human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll‐like receptor‐4 agonist and stable emulsion adjuvant
  publication-title: Vaccine
– volume: 7
  start-page: 13324
  year: 2016
  article-title: Saponin‐based adjuvants induce cross‐presentation in dendritic cells by intracellular lipid body formation
  publication-title: Nat. Commun.
– volume: 71
  start-page: 5827
  year: 2011
  end-page: 5837
  article-title: Potent antitumor immunity generated by a CD40‐targeted adenoviral vaccine
  publication-title: Cancer Res.
– volume: 33
  start-page: 1974
  year: 2015
  end-page: 1982
  article-title: Immune checkpoint blockade in cancer therapy
  publication-title: J. Clin. Oncol.
– volume: 24
  start-page: 172
  year: 2001
  end-page: 183
  article-title: Mannan mucin‐1 peptide immunization: influence of cyclophosphamide and the route of injection
  publication-title: J. Immunother. (1991)
– volume: 207
  start-page: 1283
  year: 2010
  end-page: 1292
  article-title: The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8a+ dendritic cells
  publication-title: J. Exp. Med.
– volume: 17
  start-page: 2
  year: 2016
  end-page: 8
  article-title: The development and maintenance of resident macrophages
  publication-title: Nat. Immunol.
– volume: 8
  start-page: e70237
  year: 2013
  article-title: IL‐10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation
  publication-title: PLoS One
– volume: 27
  start-page: 481
  year: 2007
  end-page: 492
  article-title: Antigen crosspresentation by human plasmacytoid dendritic cells
  publication-title: Immunity
– volume: 42
  start-page: 979
  year: 2005
  end-page: 985
  article-title: Single chain antibody fragments for the selective targeting of antigens to dendritic cells
  publication-title: Mol. Immunol.
– volume: 213
  start-page: 2871
  year: 2016
  end-page: 2883
  article-title: RAB43 facilitates cross‐presentation of cell‐associated antigens by CD8a+ dendritic cells
  publication-title: J. Exp. Med.
– volume: 113
  start-page: 191
  year: 2017
  end-page: 202
  article-title: Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate‐loaded chitosan nanoparticles vaccine
  publication-title: Biomaterials
– volume: 47
  start-page: 164
  year: 2009
  end-page: 174
  article-title: Targeting glycan modified OVA to murine DC‐SIGN transgenic dendritic cells enhances MHC class I and II presentation
  publication-title: Mol. Immunol.
– volume: 285
  start-page: 19193
  year: 2010
  end-page: 19204
  article-title: Distribution and function of macrophage galactose‐type C‐type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells
  publication-title: J. Biol. Chem.
– volume: 30
  start-page: 324
  year: 2016
  end-page: 336
  article-title: Critical role for CD103+/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma
  publication-title: Cancer Cell
– volume: 6
  start-page: 1191
  year: 2014
  end-page: 1204
  article-title: Murine langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross‐tolerance
  publication-title: EMBO Mol. Med.
– volume: 111
  start-page: 3086
  year: 2014
  end-page: 3091
  article-title: Nonagonistic Dectin‐1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 12
  start-page: 1662
  year: 2015
  end-page: 1672
  article-title: Rational design of adjuvant for skin delivery: conjugation of synthetic ß‐Glucan Dectin‐1 agonist to protein antigen
  publication-title: Mol. Pharm.
– volume: 6
  start-page: 232ra51
  year: 2014
  article-title: Induction of antigen‐specific immunity with a vaccine targeting NY‐ESO‐1 to the dendritic cell receptor DEC‐205
  publication-title: Sci. Transl. Med.
– volume: 15
  start-page: 7412
  year: 2009
  end-page: 7420
  article-title: Guidelines for the evaluation of immune therapy activity in solid tumors: immune‐related response criteria
  publication-title: Clin. Cancer Res.
– volume: 108
  start-page: 2384
  year: 2011
  end-page: 2389
  article-title: Comparable T helper 1 (Th1) and CD8 T‐cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to langerin, DEC205, and Clec9A
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 14
  start-page: 8169
  year: 2008
  end-page: 8177
  article-title: Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti‐DEC‐205 single‐chain fragment variable molecule
  publication-title: Clin. Cancer Res.
– volume: 192
  start-page: 5776
  year: 2014
  end-page: 5788
  article-title: Induction and activation of human Th17 by targeting antigens to dendritic cells via Dectin‐1
  publication-title: J. Immunol.
– volume: 112
  start-page: 4971
  year: 2008
  end-page: 4980
  article-title: Stimulation of dendritic cells via the Dectin‐1/Syk pathway allows priming of cytotoxic T‐cell responses
  publication-title: Blood
– volume: 197
  start-page: 2715
  year: 2016
  end-page: 2725
  article-title: CLEC12A‐mediated antigen uptake and cross‐presentation by human dendritic cell subsets efficiently boost tumor‐reactive T cell responses
  publication-title: J. Immunol.
– volume: 34
  start-page: 482
  year: 2013
  end-page: 486
  article-title: The physiological role of DC‐SIGN: a tale of mice and men
  publication-title: Trends Immunol.
– volume: 61
  start-page: 181
  year: 2011
  ident: 2023013012234150500_B8
  article-title: Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-011-1039-x
– volume: 26
  start-page: 638
  year: 2014
  ident: 2023013012234150500_B56
  article-title: Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2014.09.007
– volume: 44
  start-page: 1947
  year: 2014
  ident: 2023013012234150500_B164
  article-title: Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201344076
– volume: 106
  start-page: 1278
  year: 2005
  ident: 2023013012234150500_B225
  article-title: Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
  publication-title: Blood
  doi: 10.1182/blood-2005-01-0318
– volume: 13
  start-page: 2961
  year: 2007
  ident: 2023013012234150500_B271
  article-title: Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-0050
– volume: 22
  start-page: 33
  year: 2004
  ident: 2023013012234150500_B119
  article-title: Self- and nonself-recognition by C-type lectins on dendritic cells
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.22.012703.104558
– volume: 41
  start-page: 98
  year: 2008
  ident: 2023013012234150500_B138
  article-title: Targeted cancer therapy: conferring specificity to cytotoxic drugs
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar700108g
– volume: 176
  start-page: 426
  year: 2006
  ident: 2023013012234150500_B224
  article-title: Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.176.1.426
– volume: 158
  start-page: 73
  year: 2014
  ident: 2023013012234150500_B71
  article-title: Cross-presentation by human dendritic cell subsets
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2013.12.001
– volume: 17
  start-page: 1984
  year: 2011
  ident: 2023013012234150500_B7
  article-title: Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-3421
– volume: 168
  start-page: 782
  year: 2002
  ident: 2023013012234150500_B191
  article-title: Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.168.2.782
– volume: 34
  start-page: 440
  year: 2013
  ident: 2023013012234150500_B67
  article-title: Inflammatory dendritic cells in mice and humans
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2013.06.001
– volume: 7
  start-page: 1200
  year: 2006
  ident: 2023013012234150500_B249
  article-title: Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1390
– volume: 31
  start-page: 502
  year: 2009
  ident: 2023013012234150500_B41
  article-title: Intestinal lamina propria dendritic cell subsets have different origin and functions
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.06.025
– volume: 8
  start-page: 824
  year: 2006
  ident: 2023013012234150500_B213
  article-title: Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.910
– volume: 130
  start-page: 755
  year: 2010
  ident: 2023013012234150500_B195
  article-title: Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis
  publication-title: J. Invest. Dermatol.
  doi: 10.1038/jid.2009.343
– volume: 213
  start-page: 2861
  year: 2016
  ident: 2023013012234150500_B38
  article-title: Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20161135
– volume: 191
  start-page: 5005
  year: 2013
  ident: 2023013012234150500_B155
  article-title: Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1300787
– volume: 4
  start-page: 1953
  year: 2004
  ident: 2023013012234150500_B201
  article-title: Mannose receptor-targeted vaccines
  publication-title: Expert Opin. Biol. Ther.
  doi: 10.1517/14712598.4.12.1953
– volume: 156
  start-page: 128
  year: 1996
  ident: 2023013012234150500_B242
  article-title: Molecular cloning and expression of cDNA encoding human macrophage C-type lectin. Its unique carbohydrate binding specificity for Tn antigen
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.156.1.128
– volume: 19
  start-page: 2385
  year: 2008
  ident: 2023013012234150500_B220
  article-title: Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc8002524
– volume: 116
  start-page: 3828
  year: 2010
  ident: 2023013012234150500_B151
  article-title: Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody
  publication-title: Blood
  doi: 10.1182/blood-2010-06-288068
– volume: 184
  start-page: 1953
  year: 1996
  ident: 2023013012234150500_B17
  article-title: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.184.5.1953
– volume: 4
  start-page: 8
  year: 2016
  ident: 2023013012234150500_B137
  article-title: Direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies
  publication-title: Vaccines (Basel)
  doi: 10.3390/vaccines4020008
– volume: 45
  start-page: 669
  year: 2016
  ident: 2023013012234150500_B36
  article-title: Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.08.015
– volume: 97
  start-page: 627
  year: 2015
  ident: 2023013012234150500_B193
  article-title: langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1HI0714-351R
– volume: 106
  start-page: 1659
  year: 2015
  ident: 2023013012234150500_B273
  article-title: Adjuvant for vaccine immunotherapy of cancer–focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity
  publication-title: Cancer Sci.
  doi: 10.1111/cas.12824
– volume: 82
  start-page: 515
  year: 2015
  ident: 2023013012234150500_B168
  article-title: Enhanced humoral responses induced by targeting of antigen to murine dendritic cells
  publication-title: Scand. J. Immunol.
  doi: 10.1111/sji.12387
– volume: 176
  start-page: 4431
  year: 2006
  ident: 2023013012234150500_B85
  article-title: The vast majority of CLA+ T cells are resident in normal skin
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.176.7.4431
– volume: 131
  start-page: 641
  year: 2007
  ident: 2023013012234150500_B83
  article-title: Antigen presentation the macrophage way
  publication-title: Cell
  doi: 10.1016/j.cell.2007.10.046
– volume: 14
  start-page: 986
  year: 2013
  ident: 2023013012234150500_B75
  article-title: Tissue-resident macrophages
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2705
– volume: 32
  start-page: 4574
  year: 2011
  ident: 2023013012234150500_B211
  article-title: Antitumor activity of liposomal ErbB2/HER2 epitope peptide-based vaccine constructs incorporating TLR agonists and mannose receptor targeting
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2011.03.015
– volume: 162
  start-page: 1322
  year: 2015
  ident: 2023013012234150500_B64
  article-title: Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions
  publication-title: Cell
  doi: 10.1016/j.cell.2015.08.004
– volume: 22
  start-page: 1897
  year: 2016
  ident: 2023013012234150500_B5
  article-title: Dendritic cell-based immunotherapy: state of the art and beyond
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1399
– volume: 38
  start-page: 424
  year: 2008
  ident: 2023013012234150500_B216
  article-title: Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200737578
– volume: 181
  start-page: 2455
  year: 2008
  ident: 2023013012234150500_B215
  article-title: The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.4.2455
– volume: 351
  start-page: 181
  year: 2012
  ident: 2023013012234150500_B86
  article-title: The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma
  publication-title: Curr. Top. Microbiol. Immunol.
– volume: 135
  start-page: 2228
  year: 2015
  ident: 2023013012234150500_B239
  article-title: In situ delivery of sntigen to DC-SIGN+ CD14+ dermal dendritic cells results in enhanced CD8+ T-cell responses
  publication-title: J. Invest. Dermatol.
  doi: 10.1038/jid.2015.152
– volume: 213
  start-page: 2871
  year: 2016
  ident: 2023013012234150500_B68
  article-title: RAB43 facilitates cross-presentation of cell-associated antigens by CD8a+ dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20160597
– volume: 34
  start-page: 2847
  year: 2016
  ident: 2023013012234150500_B148
  article-title: A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.04.002
– volume: 39
  start-page: 733
  year: 2013
  ident: 2023013012234150500_B58
  article-title: CD301b+ dermal dendritic cells drive T helper 2 cell-mediated immunity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.08.029
– volume: 449
  start-page: 419
  year: 2007
  ident: 2023013012234150500_B11
  article-title: Taking dendritic cells into medicine
  publication-title: Nature
  doi: 10.1038/nature06175
– volume: 14
  start-page: 417
  year: 2014
  ident: 2023013012234150500_B87
  article-title: The origins and functions of dendritic cells and macrophages in the skin
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3683
– start-page: 115
  volume-title: Essentials of Glycobiology
  year: 2009
  ident: 2023013012234150500_B121
– volume: 116
  start-page: 1685
  year: 2010
  ident: 2023013012234150500_B162
  article-title: Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR
  publication-title: Blood
  doi: 10.1182/blood-2010-01-264960
– volume: 15
  start-page: 471
  year: 2015
  ident: 2023013012234150500_B49
  article-title: The multifaceted biology of plasmacytoid dendritic cells
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3865
– volume: 34
  start-page: 4857
  year: 2016
  ident: 2023013012234150500_B158
  article-title: Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.08.071
– volume: 111
  start-page: 4245
  year: 2008
  ident: 2023013012234150500_B131
  article-title: Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-a production
  publication-title: Blood
  doi: 10.1182/blood-2007-03-081398
– volume: 14
  start-page: 930
  year: 1996
  ident: 2023013012234150500_B205
  article-title: Cell-mediated immune responses to MUC1 fusion protein coupled to mannan
  publication-title: Vaccine
  doi: 10.1016/0264-410X(95)00258-3
– volume: 30
  start-page: 324
  year: 2016
  ident: 2023013012234150500_B55
  article-title: Critical role for CD103+/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.06.003
– volume: 17
  start-page: 661
  year: 2005
  ident: 2023013012234150500_B132
  article-title: Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxh246
– volume: 16
  start-page: 406
  year: 2015
  ident: 2023013012234150500_B77
  article-title: Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8+ T cells responding to infection
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3108
– volume: 12
  start-page: 2826
  year: 2006
  ident: 2023013012234150500_B114
  article-title: Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-2431
– volume: 28
  start-page: 2288
  year: 2011
  ident: 2023013012234150500_B219
  article-title: Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-011-0459-9
– volume: 42
  start-page: 979
  year: 2005
  ident: 2023013012234150500_B141
  article-title: Single chain antibody fragments for the selective targeting of antigens to dendritic cells
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2004.09.034
– volume: 129
  start-page: 26
  year: 2008
  ident: 2023013012234150500_B218
  article-title: Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2008.03.023
– volume: 458
  start-page: 899
  year: 2009
  ident: 2023013012234150500_B173
  article-title: Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
  publication-title: Nature
  doi: 10.1038/nature07750
– volume: 37
  start-page: 267
  year: 2014
  ident: 2023013012234150500_B6
  article-title: Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies
  publication-title: J. Immunother.
  doi: 10.1097/CJI.0000000000000035
– volume: 5
  start-page: 16
  year: 2017
  ident: 2023013012234150500_B2
  article-title: Combination immunotherapy: a road map
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-017-0218-5
– volume: 110
  start-page: 7826
  year: 2013
  ident: 2023013012234150500_B258
  article-title: Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1219888110
– volume: 77
  start-page: 85
  year: 2015
  ident: 2023013012234150500_B110
  article-title: Human skin dendritic cells in health and disease
  publication-title: J. Dermatol. Sci.
  doi: 10.1016/j.jdermsci.2014.08.012
– volume: 23
  start-page: 909
  year: 2014
  ident: 2023013012234150500_B159
  article-title: Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors
  publication-title: Exp. Dermatol.
  doi: 10.1111/exd.12573
– volume: 324
  start-page: 392
  year: 2009
  ident: 2023013012234150500_B16
  article-title: In vivo analysis of dendritic cell development and homeostasis
  publication-title: Science
  doi: 10.1126/science.1170540
– volume: 6
  start-page: 1191
  year: 2014
  ident: 2023013012234150500_B196
  article-title: Murine langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance
  publication-title: EMBO Mol. Med.
  doi: 10.15252/emmm.201303283
– volume: 43
  start-page: 2543
  year: 2013
  ident: 2023013012234150500_B229
  article-title: In vivo targeting of human DC-SIGN drastically enhances CD8+ T-cell-mediated protective immunity
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201343429
– volume: 100
  start-page: 575
  year: 2000
  ident: 2023013012234150500_B125
  article-title: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80693-5
– volume: 7
  start-page: e40208
  year: 2012
  ident: 2023013012234150500_B149
  article-title: Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0040208
– volume: 212
  start-page: 743
  year: 2015
  ident: 2023013012234150500_B197
  article-title: Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20131675
– volume: 346
  start-page: 93
  year: 2014
  ident: 2023013012234150500_B76
  article-title: T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells
  publication-title: Science
  doi: 10.1126/science.1257530
– volume: 95
  start-page: 3489
  year: 2000
  ident: 2023013012234150500_B19
  article-title: Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells
  publication-title: Blood
  doi: 10.1182/blood.V95.11.3489
– volume: 42
  start-page: 101
  year: 2012
  ident: 2023013012234150500_B147
  article-title: A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201141855
– volume: 7
  start-page: 255
  year: 2007
  ident: 2023013012234150500_B251
  article-title: Siglecs and their roles in the immune system
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2056
– volume: 17
  start-page: 211
  year: 2002
  ident: 2023013012234150500_B52
  article-title: In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens
  publication-title: Immunity
  doi: 10.1016/S1074-7613(02)00365-5
– volume: 71
  start-page: 5827
  year: 2011
  ident: 2023013012234150500_B269
  article-title: Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-11-0804
– volume: 100
  start-page: 2783
  year: 1997
  ident: 2023013012234150500_B262
  article-title: Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI119825
– volume: 34
  start-page: 482
  year: 2013
  ident: 2023013012234150500_B222
  article-title: The physiological role of DC-SIGN: a tale of mice and men
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2013.03.001
– volume: 16
  start-page: 718
  year: 2015
  ident: 2023013012234150500_B37
  article-title: Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3200
– volume: 204
  start-page: 3133
  year: 2007
  ident: 2023013012234150500_B101
  article-title: Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20071733
– volume: 1253
  start-page: 149
  year: 2012
  ident: 2023013012234150500_B124
  article-title: An evolutionary perspective on C-type lectins in infection and immunity
  publication-title: Ann. N. Y. Acad. Sci
  doi: 10.1111/j.1749-6632.2011.06392.x
– volume: 85
  start-page: 518
  year: 2008
  ident: 2023013012234150500_B130
  article-title: DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0608352
– volume: 9
  start-page: 250
  year: 2013
  ident: 2023013012234150500_B150
  article-title: Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.1186
– volume: 285
  start-page: 19193
  year: 2010
  ident: 2023013012234150500_B244
  article-title: Distribution and function of macrophage galactose-type C-type lectin 2 (MGL2/CD301b): efficient uptake and presentation of glycosylated antigens by dendritic cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.113613
– volume: 21
  start-page: 81
  year: 2015
  ident: 2023013012234150500_B279
  article-title: High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
  publication-title: Nat. Med.
  doi: 10.1038/nm.3773
– volume: 24
  start-page: 172
  year: 2001
  ident: 2023013012234150500_B263
  article-title: Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection
  publication-title: J. Immunother. (1991)
  doi: 10.1097/00002371-200103000-00012
– volume: 315
  start-page: 107
  year: 2007
  ident: 2023013012234150500_B54
  article-title: Differential antigen processing by dendritic cell subsets in vivo
  publication-title: Science
  doi: 10.1126/science.1136080
– volume: 64
  start-page: 8456
  year: 2004
  ident: 2023013012234150500_B113
  article-title: Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-03-3251
– volume: 7
  start-page: 40437
  year: 2016
  ident: 2023013012234150500_B174
  article-title: A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9624
– volume: 41
  start-page: 2573
  year: 2011
  ident: 2023013012234150500_B143
  article-title: Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201141526
– volume: 515
  start-page: 568
  year: 2014
  ident: 2023013012234150500_B3
  article-title: PD-1 blockade induces responses by inhibiting adaptive immune resistance
  publication-title: Nature
  doi: 10.1038/nature13954
– volume: 13
  start-page: 1118
  year: 2012
  ident: 2023013012234150500_B20
  article-title: Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2419
– volume: 143
  start-page: 416
  year: 2010
  ident: 2023013012234150500_B46
  article-title: Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209+ dendritic cells for immune T cell areas
  publication-title: Cell
  doi: 10.1016/j.cell.2010.09.039
– volume: 81
  start-page: 143
  year: 2017
  ident: 2023013012234150500_B181
  article-title: Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2016.12.010
– volume: 6
  start-page: 232ra51
  year: 2014
  ident: 2023013012234150500_B264
  article-title: Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3008068
– volume: 112
  start-page: 4971
  year: 2008
  ident: 2023013012234150500_B190
  article-title: Stimulation of dendritic cells via the Dectin-1/Syk pathway allows priming of cytotoxic T-cell responses
  publication-title: Blood
  doi: 10.1182/blood-2008-05-158469
– volume: 34
  start-page: 85
  year: 2011
  ident: 2023013012234150500_B257
  article-title: CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.12.011
– volume: 9
  start-page: 679
  year: 2009
  ident: 2023013012234150500_B84
  article-title: Skin immune sentinels in health and disease
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2622
– volume: 14
  start-page: 360
  year: 2017
  ident: 2023013012234150500_B104
  article-title: Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/cmi.2015.87
– volume: 1
  start-page: e87102
  year: 2016
  ident: 2023013012234150500_B170
  article-title: Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.87102
– volume: 207
  start-page: 1273
  year: 2010
  ident: 2023013012234150500_B24
  article-title: Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20100348
– volume: 13
  start-page: 753
  year: 2012
  ident: 2023013012234150500_B92
  article-title: IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2360
– volume: 8
  start-page: e70237
  year: 2013
  ident: 2023013012234150500_B109
  article-title: IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0070237
– volume: 67
  start-page: 8358
  year: 2007
  ident: 2023013012234150500_B247
  article-title: Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-1035
– volume: 1
  start-page: eaai7677
  year: 2016
  ident: 2023013012234150500_B73
  article-title: Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment
  publication-title: Sci. Immunol.
  doi: 10.1126/sciimmunol.aai7677
– volume: 18
  start-page: 857
  year: 2006
  ident: 2023013012234150500_B153
  article-title: Expression of human DEC-205 (CD205) multilectin receptor on leukocytes
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxl022
– volume: 111
  start-page: 1942
  year: 2008
  ident: 2023013012234150500_B32
  article-title: The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse
  publication-title: Blood
  doi: 10.1182/blood-2007-07-100750
– volume: 8
  start-page: e52875
  year: 2013
  ident: 2023013012234150500_B72
  article-title: Transcriptional profiling of human dendritic cell populations and models—unique profiles of in vitro dendritic cells and implications on functionality and applicability
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0052875
– volume: 6
  start-page: 534
  year: 2015
  ident: 2023013012234150500_B89
  article-title: Functional specialization of skin dendritic cell subsets in regulating T cell responses
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2015.00534
– volume: 203
  start-page: 67
  year: 2015
  ident: 2023013012234150500_B103
  article-title: Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2015.01.040
– volume: 8
  start-page: 578
  year: 2007
  ident: 2023013012234150500_B15
  article-title: Origin of dendritic cells in peripheral lymphoid organs of mice
  publication-title: Nat. Immunol.
  doi: 10.1038/ni1462
– volume: 38
  start-page: 970
  year: 2013
  ident: 2023013012234150500_B62
  article-title: IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.04.011
– volume: 4
  start-page: 734
  year: 2016
  ident: 2023013012234150500_B277
  article-title: Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-16-0001
– volume: 7
  start-page: e2330
  year: 2013
  ident: 2023013012234150500_B160
  article-title: Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
  publication-title: PLoS Negl. Trop. Dis.
  doi: 10.1371/journal.pntd.0002330
– volume: 18
  start-page: 1547
  year: 2007
  ident: 2023013012234150500_B238
  article-title: Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc070026g
– volume: 13
  start-page: 401
  year: 2003
  ident: 2023013012234150500_B122
  article-title: Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwg045
– volume: 37
  start-page: 60
  year: 2012
  ident: 2023013012234150500_B99
  article-title: Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.04.012
– volume: 38
  start-page: 322
  year: 2013
  ident: 2023013012234150500_B47
  article-title: Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.10.016
– volume: 322
  start-page: 1097
  year: 2008
  ident: 2023013012234150500_B29
  article-title: Batf3 deficiency reveals a critical role for CD8a+ dendritic cells in cytotoxic T cell immunity
  publication-title: Science
  doi: 10.1126/science.1164206
– volume: 6
  start-page: 498
  year: 2013
  ident: 2023013012234150500_B44
  article-title: Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2012.89
– volume: 12
  start-page: 1662
  year: 2015
  ident: 2023013012234150500_B186
  article-title: Rational design of adjuvant for skin delivery: conjugation of synthetic ß-Glucan Dectin-1 agonist to protein antigen
  publication-title: Mol. Pharm.
  doi: 10.1021/acs.molpharmaceut.5b00072
– volume: 10
  start-page: 1920
  year: 2004
  ident: 2023013012234150500_B204
  article-title: A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin ß
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-03-0264
– volume: 37
  start-page: 2075
  year: 2007
  ident: 2023013012234150500_B243
  article-title: MGL-mediated internalization and antigen presentation by dendritic cells: a role for tyrosine-5
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200636838
– volume: 18
  start-page: 3174
  year: 2000
  ident: 2023013012234150500_B206
  article-title: Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(00)00090-6
– volume: 279
  start-page: 14792
  year: 2004
  ident: 2023013012234150500_B175
  article-title: Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M313127200
– volume: 7
  start-page: e39039
  year: 2012
  ident: 2023013012234150500_B259
  article-title: Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039039
– volume: 181
  start-page: 3148
  year: 2008
  ident: 2023013012234150500_B250
  article-title: The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.181.5.3148
– volume: 53
  start-page: 1387
  year: 2010
  ident: 2023013012234150500_B214
  article-title: Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization
  publication-title: J. Med. Chem.
  doi: 10.1021/jm901295s
– volume: 174
  start-page: 6592
  year: 2005
  ident: 2023013012234150500_B34
  article-title: Cutting edge: generation of splenic CD8+ and CD8– dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.174.11.6592
– volume: 163
  start-page: 1973
  year: 1999
  ident: 2023013012234150500_B127
  article-title: APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.163.4.1973
– volume: 45
  start-page: 854
  year: 2015
  ident: 2023013012234150500_B166
  article-title: Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201445127
– volume: 33
  start-page: 1974
  year: 2015
  ident: 2023013012234150500_B1
  article-title: Immune checkpoint blockade in cancer therapy
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2014.59.4358
– volume: 41
  start-page: 1014
  year: 2011
  ident: 2023013012234150500_B154
  article-title: DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201040790
– volume: 192
  start-page: 1685
  year: 2000
  ident: 2023013012234150500_B53
  article-title: CD8+ but not CD8– dendritic cells cross-prime cytotoxic T cells in vivo
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.192.12.1685
– volume: 51
  start-page: 10472
  year: 2012
  ident: 2023013012234150500_B139
  article-title: Multivalency as a chemical organization and action principle
  publication-title: Angew. Chem. Int. Ed. Engl.
  doi: 10.1002/anie.201201114
– volume: 118
  start-page: 2502
  year: 2011
  ident: 2023013012234150500_B105
  article-title: Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation
  publication-title: Blood
  doi: 10.1182/blood-2011-03-344838
– volume: 168
  start-page: 2118
  year: 2002
  ident: 2023013012234150500_B223
  article-title: The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.168.5.2118
– volume: 38
  start-page: 1157
  year: 2008
  ident: 2023013012234150500_B178
  article-title: Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200738057
– volume: 10
  start-page: 733
  year: 2011
  ident: 2023013012234150500_B261
  article-title: CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer
  publication-title: Expert Rev. Vaccines
  doi: 10.1586/erv.11.20
– volume: 44
  start-page: 2415
  year: 2014
  ident: 2023013012234150500_B275
  article-title: Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201344094
– volume: 26
  start-page: 326
  year: 2008
  ident: 2023013012234150500_B235
  article-title: Engineered lentivector targeting of dendritic cells for in vivo immunization
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1390
– volume: 113
  start-page: E7759
  year: 2016
  ident: 2023013012234150500_B4
  article-title: Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1609376113
– volume: 192
  start-page: 5830
  year: 2014
  ident: 2023013012234150500_B161
  article-title: Antigen delivery to CD11c+CD8– dendritic cells induces protective immune responses against experimental melanoma in mice in vivo
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1300975
– volume: 15
  start-page: 929
  year: 2014
  ident: 2023013012234150500_B40
  article-title: Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2967
– volume: 3
  start-page: e28836
  year: 2014
  ident: 2023013012234150500_B278
  article-title: High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
  publication-title: OncoImmunology
  doi: 10.4161/onci.28836
– volume: 38
  start-page: 2389
  year: 2008
  ident: 2023013012234150500_B14
  article-title: Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200838470
– volume: 209
  start-page: 653
  year: 2012
  ident: 2023013012234150500_B106
  article-title: Characterization of resident and migratory dendritic cells in human lymph nodes
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20111457
– volume: 46
  start-page: 1240
  year: 2009
  ident: 2023013012234150500_B133
  article-title: Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2008.11.021
– volume: 73
  start-page: 1063
  year: 2013
  ident: 2023013012234150500_B9
  article-title: Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-2583
– volume: 31
  start-page: 513
  year: 2009
  ident: 2023013012234150500_B42
  article-title: Origin of the lamina propria dendritic cell network
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.08.010
– volume: 206
  start-page: 3089
  year: 2009
  ident: 2023013012234150500_B93
  article-title: Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20091586
– volume: 92
  start-page: 1177
  year: 2012
  ident: 2023013012234150500_B126
  article-title: The mannose receptor
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0512231
– volume: 4
  start-page: 403
  year: 2013
  ident: 2023013012234150500_B74
  article-title: Dendritic cell plasticity in tumor-conditioned skin: CD14+ cells at the cross-roads of immune activation and suppression
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00403
– volume: 43
  start-page: 554
  year: 2015
  ident: 2023013012234150500_B65
  article-title: Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.07.020
– volume: 30
  start-page: 715
  year: 2007
  ident: 2023013012234150500_B228
  article-title: In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models
  publication-title: J. Immunother.
  doi: 10.1097/CJI.0b013e318135472c
– volume: 116
  start-page: 3526
  year: 2010
  ident: 2023013012234150500_B246
  article-title: Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvant
  publication-title: Blood
  doi: 10.1182/blood-2010-04-279133
– volume: 15
  start-page: 7412
  year: 2009
  ident: 2023013012234150500_B265
  article-title: Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-09-1624
– volume: 14
  start-page: 8169
  year: 2008
  ident: 2023013012234150500_B140
  article-title: Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-1474
– volume: 46
  start-page: S77
  year: 2000
  ident: 2023013012234150500_B217
  article-title: Development of a cancer vaccine: peptides, proteins, and DNA
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s002800000179
– volume: 207
  start-page: 1283
  year: 2010
  ident: 2023013012234150500_B23
  article-title: The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8a+ dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20100223
– volume: 45
  start-page: 1205
  year: 2016
  ident: 2023013012234150500_B48
  article-title: The heterogeneity of Ly6Chi monocytes controls their differentiation into iNOS+ macrophages or monocyte-derived dendritic cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.12.001
– volume: 119
  start-page: 2284
  year: 2012
  ident: 2023013012234150500_B169
  article-title: The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells
  publication-title: Blood
  doi: 10.1182/blood-2011-08-373944
– volume: 6
  start-page: e16827
  year: 2011
  ident: 2023013012234150500_B255
  article-title: Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016827
– volume: 3
  start-page: e21
  year: 2014
  ident: 2023013012234150500_B207
  article-title: Dendritic cell immunotherapy: clinical outcomes
  publication-title: Clin. Transl. Immunology
  doi: 10.1038/cti.2014.14
– volume: 207
  start-page: 823
  year: 2010
  ident: 2023013012234150500_B30
  article-title: Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8a+ conventional dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20091627
– volume: 197
  start-page: 2715
  year: 2016
  ident: 2023013012234150500_B182
  article-title: CLEC12A-mediated antigen uptake and cross-presentation by human dendritic cell subsets efficiently boost tumor-reactive T cell responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1600011
– volume: 2
  start-page: e00757
  year: 2013
  ident: 2023013012234150500_B60
  article-title: EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture
  publication-title: eLife
  doi: 10.7554/eLife.00757
– volume: 3
  start-page: 48
  year: 2015
  ident: 2023013012234150500_B118
  article-title: High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-14-0149
– volume: 207
  start-page: 1261
  year: 2010
  ident: 2023013012234150500_B26
  article-title: Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20092618
– volume: 112
  start-page: 5461
  year: 2015
  ident: 2023013012234150500_B82
  article-title: CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1423356112
– volume: 187
  start-page: 842
  year: 2011
  ident: 2023013012234150500_B167
  article-title: Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1101176
– volume: 23
  start-page: 28
  year: 2016
  ident: 2023013012234150500_B95
  article-title: Langerhans cell origin and regulation
  publication-title: Curr. Opin. Hematol.
  doi: 10.1097/MOH.0000000000000202
– volume: 116
  start-page: 2277
  year: 2010
  ident: 2023013012234150500_B156
  article-title: Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation
  publication-title: Blood
  doi: 10.1182/blood-2010-02-268425
– volume: 7
  start-page: 790
  year: 2007
  ident: 2023013012234150500_B12
  article-title: Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2173
– volume: 5
  start-page: 606
  year: 2005
  ident: 2023013012234150500_B79
  article-title: Structure and function of the spleen
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri1669
– volume: 38
  start-page: 41
  year: 2015
  ident: 2023013012234150500_B236
  article-title: Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy
  publication-title: J. Immunother.
  doi: 10.1097/CJI.0000000000000067
– volume: 211
  start-page: 651
  year: 2006
  ident: 2023013012234150500_B272
  article-title: Immunomodulation of the melanoma sentinel lymph node: a novel adjuvant therapeutic option
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2006.06.009
– volume: 12
  start-page: 71
  year: 2000
  ident: 2023013012234150500_B192
  article-title: langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80160-0
– volume: 35
  start-page: 541
  year: 2013
  ident: 2023013012234150500_B78
  article-title: Macrophage heterogeneity in lymphoid tissues
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-013-0378-4
– volume: 193
  start-page: 2297
  year: 2014
  ident: 2023013012234150500_B281
  article-title: Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1400489
– volume: 127
  start-page: 1
  year: 2015
  ident: 2023013012234150500_B70
  article-title: Cross-presentation in mouse and human dendritic cells
  publication-title: Adv. Immunol.
  doi: 10.1016/bs.ai.2015.03.002
– volume: 36
  start-page: 635
  year: 2012
  ident: 2023013012234150500_B172
  article-title: F-actin is an evolutionarilyconserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.03.008
– volume: 277
  start-page: 20686
  year: 2002
  ident: 2023013012234150500_B241
  article-title: The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M202104200
– volume: 316
  start-page: 612
  year: 2007
  ident: 2023013012234150500_B200
  article-title: Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
  publication-title: Science
  doi: 10.1126/science.1137971
– volume: 121
  start-page: 5034
  year: 2013
  ident: 2023013012234150500_B157
  article-title: CD141+ dendritic cells produce prominent amounts of IFN-a after dsRNA recognition and can be targeted via DEC-205 in humanized mice
  publication-title: Blood
  doi: 10.1182/blood-2012-12-473413
– volume: 41
  start-page: 916
  year: 2011
  ident: 2023013012234150500_B209
  article-title: Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201040762
– volume: 31
  start-page: 823
  year: 2009
  ident: 2023013012234150500_B25
  article-title: Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.08.027
– volume: 91
  start-page: 437
  year: 2012
  ident: 2023013012234150500_B180
  article-title: Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0711384
– volume: 29
  start-page: 4813
  year: 2011
  ident: 2023013012234150500_B254
  article-title: Delivery of antigen to sialoadhesin or CD163 improves the specific immune response in pigs
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.04.076
– volume: 199
  start-page: 815
  year: 2004
  ident: 2023013012234150500_B135
  article-title: In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20032220
– volume: 45
  start-page: 747
  year: 2015
  ident: 2023013012234150500_B80
  article-title: Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201444983
– volume: 22
  start-page: 1903
  year: 2004
  ident: 2023013012234150500_B221
  article-title: Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2003.11.008
– volume: 33
  start-page: 4229
  year: 2012
  ident: 2023013012234150500_B240
  article-title: Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.02.036
– volume: 34
  start-page: 93
  year: 2016
  ident: 2023013012234150500_B63
  article-title: Transcriptional control of dendritic cell development
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-032713-120204
– volume: 17
  start-page: 2
  year: 2016
  ident: 2023013012234150500_B39
  article-title: The development and maintenance of resident macrophages
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3341
– volume: 196
  start-page: 1415
  year: 2002
  ident: 2023013012234150500_B35
  article-title: ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8a+ dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20021263
– volume: 107
  start-page: 1459
  year: 2006
  ident: 2023013012234150500_B176
  article-title: Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production
  publication-title: Blood
  doi: 10.1182/blood-2005-08-3264
– volume: 113
  start-page: 191
  year: 2017
  ident: 2023013012234150500_B212
  article-title: Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.10.047
– volume: 180
  start-page: 3647
  year: 2008
  ident: 2023013012234150500_B102
  article-title: Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.6.3647
– volume: 7
  start-page: 13324
  year: 2016
  ident: 2023013012234150500_B274
  article-title: Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms13324
– volume: 209
  start-page: 1825
  year: 2012
  ident: 2023013012234150500_B61
  article-title: Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20120774
– volume: 121
  start-page: 174
  year: 2007
  ident: 2023013012234150500_B234
  article-title: Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2007.02554.x
– volume: 3
  start-page: 495
  year: 2015
  ident: 2023013012234150500_B116
  article-title: Arming the melanoma sentinel lymph node through local administration of CpG-B and GM-CSF: recruitment and activation of BDCA3/CD141+ dendritic cells and enhanced cross-presentation
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-14-0165
– volume: 182
  start-page: 7587
  year: 2009
  ident: 2023013012234150500_B179
  article-title: The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900464
– volume: 111
  start-page: 3086
  year: 2014
  ident: 2023013012234150500_B189
  article-title: Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1319268111
– volume: 14
  start-page: 571
  year: 2014
  ident: 2023013012234150500_B22
  article-title: Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3712
– volume: 4
  start-page: e970462
  year: 2014
  ident: 2023013012234150500_B230
  article-title: Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
  publication-title: OncoImmunology
  doi: 10.4161/21624011.2014.970462
– volume: 22
  start-page: 2155
  year: 2016
  ident: 2023013012234150500_B10
  article-title: Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-2205
– volume: 14
  start-page: 39
  year: 2013
  ident: 2023013012234150500_B142
  article-title: DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
  publication-title: BMC Immunol.
  doi: 10.1186/1471-2172-14-39
– volume: 4
  start-page: 157
  year: 2013
  ident: 2023013012234150500_B268
  article-title: Skin-resident antigen-presenting cells: instruction manual for vaccine development
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2013.00157
– volume: 13
  start-page: 4490
  year: 1994
  ident: 2023013012234150500_B252
  article-title: Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1994.tb06771.x
– volume: 10
  start-page: 1661
  year: 1991
  ident: 2023013012234150500_B253
  article-title: Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1991.tb07689.x
– volume: 106
  start-page: 20377
  year: 2009
  ident: 2023013012234150500_B69
  article-title: Different cross-presentation pathways in steady-state and inflammatory dendritic cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0910295106
– volume: 5
  start-page: 5
  year: 2007
  ident: 2023013012234150500_B202
  article-title: Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
  publication-title: J. Transl. Med.
  doi: 10.1186/1479-5876-5-5
– volume: 37
  start-page: 1050
  year: 2012
  ident: 2023013012234150500_B91
  article-title: Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.11.001
– volume: 192
  start-page: 209
  year: 2014
  ident: 2023013012234150500_B146
  article-title: Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: a comparative study
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2014.07.040
– volume: 84
  start-page: 143
  year: 2008
  ident: 2023013012234150500_B111
  article-title: Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.1107750
– volume: 160
  start-page: 88
  year: 2012
  ident: 2023013012234150500_B232
  article-title: Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2012.02.007
– volume: 104
  start-page: 2858
  year: 2004
  ident: 2023013012234150500_B177
  article-title: KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0878
– volume: 274
  start-page: 19087
  year: 1999
  ident: 2023013012234150500_B208
  article-title: Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.27.19087
– volume: 42
  start-page: 916
  year: 2015
  ident: 2023013012234150500_B59
  article-title: Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.04.017
– volume: 16
  start-page: 853
  year: 2004
  ident: 2023013012234150500_B123
  article-title: High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxh089
– volume: 107
  start-page: 216
  year: 2010
  ident: 2023013012234150500_B81
  article-title: Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0909541107
– volume: 185
  start-page: 3504
  year: 2010
  ident: 2023013012234150500_B184
  article-title: Concomitant activation and antigen uptake via human Dectin-1 results in potent antigen-specific CD8+ T cell responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000999
– volume: 29
  start-page: 497
  year: 2008
  ident: 2023013012234150500_B198
  article-title: Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.07.013
– volume: 209
  start-page: 1167
  year: 2012
  ident: 2023013012234150500_B90
  article-title: Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20120340
– volume: 177
  start-page: 2276
  year: 2006
  ident: 2023013012234150500_B183
  article-title: Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.177.4.2276
– volume: 194
  start-page: 769
  year: 2001
  ident: 2023013012234150500_B134
  article-title: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.194.6.769
– volume: 27
  start-page: 481
  year: 2007
  ident: 2023013012234150500_B50
  article-title: Antigen crosspresentation by human plasmacytoid dendritic cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2007.07.021
– volume: 15
  start-page: 2462
  year: 2016
  ident: 2023013012234150500_B66
  article-title: Distinct transcriptional programs control cross-priming in classical and monocyte-derived dendritic cells
  publication-title: Cell Reports
  doi: 10.1016/j.celrep.2016.05.025
– volume: 20
  start-page: 145
  year: 2011
  ident: 2023013012234150500_B94
  article-title: Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft
  publication-title: Exp. Dermatol.
  doi: 10.1111/j.1600-0625.2010.01146.x
– volume: 365
  start-page: 127
  year: 2011
  ident: 2023013012234150500_B31
  article-title: IRF8 mutations and human dendritic-cell immunodeficiency
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1100066
– volume: 196
  start-page: 1627
  year: 2002
  ident: 2023013012234150500_B136
  article-title: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20021598
– volume: 9
  start-page: 676
  year: 2008
  ident: 2023013012234150500_B18
  article-title: The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1615
– volume: 13
  start-page: 888
  year: 2012
  ident: 2023013012234150500_B21
  article-title: Deciphering the transcriptional network of the dendritic cell lineage
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.2370
– volume: 42
  start-page: 3150
  year: 2012
  ident: 2023013012234150500_B45
  article-title: CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201242847
– volume: 9
  start-page: 558
  year: 2008
  ident: 2023013012234150500_B199
  article-title: Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1601
– volume: 210
  start-page: 1035
  year: 2013
  ident: 2023013012234150500_B117
  article-title: Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20121103
– volume: 101
  start-page: 305
  year: 2003
  ident: 2023013012234150500_B33
  article-title: Essential role for ICSBP in the in vivo development of murine CD8a + dendritic cells
  publication-title: Blood
  doi: 10.1182/blood-2002-04-1088
– volume: 42
  start-page: 936
  year: 2012
  ident: 2023013012234150500_B248
  article-title: Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201142086
– volume: 193
  start-page: 961
  year: 2014
  ident: 2023013012234150500_B145
  article-title: Targeted delivery of a-galactosylceramide to CD8a+ dendritic cells optimizes type I NKT cell-based antitumor responses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1303029
– volume: 44
  start-page: 924
  year: 2016
  ident: 2023013012234150500_B57
  article-title: Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition
  publication-title: Immunity
  doi: 10.1016/j.immuni.2016.03.012
– volume: 432
  start-page: 35
  year: 2016
  ident: 2023013012234150500_B97
  article-title: Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2016.02.023
– volume: 192
  start-page: 5776
  year: 2014
  ident: 2023013012234150500_B185
  article-title: Induction and activation of human Th17 by targeting antigens to dendritic cells via Dectin-1
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1301661
– volume: 391
  start-page: 958
  year: 2010
  ident: 2023013012234150500_B188
  article-title: Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responses
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2009.11.173
– volume: 190
  start-page: 3338
  year: 2013
  ident: 2023013012234150500_B267
  article-title: Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1200598
– volume: 41
  start-page: 465
  year: 2014
  ident: 2023013012234150500_B108
  article-title: Human dermal CD14+ cells are a transient population of monocyte-derived macrophages
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.08.006
– volume: 172
  start-page: 2845
  year: 2004
  ident: 2023013012234150500_B203
  article-title: Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.5.2845
– volume: 176
  start-page: 7232
  year: 2006
  ident: 2023013012234150500_B100
  article-title: A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.176.12.7232
– volume: 180
  start-page: 4540
  year: 2008
  ident: 2023013012234150500_B112
  article-title: Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.7.4540
– start-page: 4
  year: 2016
  ident: 2023013012234150500_B120
  article-title: Lectin receptors expressed on myeloid cells
  publication-title: Microbiol. Spectr.
– volume: 135
  start-page: 37
  year: 2008
  ident: 2023013012234150500_B13
  article-title: Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development
  publication-title: Cell
  doi: 10.1016/j.cell.2008.09.016
– volume: 47
  start-page: 164
  year: 2009
  ident: 2023013012234150500_B233
  article-title: Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2009.09.026
– volume: 64
  start-page: 4357
  year: 2004
  ident: 2023013012234150500_B144
  article-title: Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-0138
– volume: 35
  start-page: 469
  year: 2017
  ident: 2023013012234150500_B88
  article-title: Antigen-presenting cells in the skin
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-051116-052215
– volume: 37
  start-page: 905
  year: 2012
  ident: 2023013012234150500_B96
  article-title: Two distinct types of Langerhans cells populate the skin during steady state and inflammation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.07.019
– volume: 283
  start-page: 16693
  year: 2008
  ident: 2023013012234150500_B165
  article-title: CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M709923200
– volume: 112
  start-page: 3713
  year: 2008
  ident: 2023013012234150500_B51
  article-title: Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation
  publication-title: Blood
  doi: 10.1182/blood-2008-03-146290
– volume: 9
  start-page: e103755
  year: 2014
  ident: 2023013012234150500_B210
  article-title: Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0103755
– volume: 65
  start-page: 405
  year: 2016
  ident: 2023013012234150500_B115
  article-title: Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-016-1811-z
– volume: 119
  start-page: 5182
  year: 2012
  ident: 2023013012234150500_B98
  article-title: Human Langerhans cells use an IL-15R-a/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
  publication-title: Blood
  doi: 10.1182/blood-2011-09-382200
– volume: 21
  start-page: 512
  year: 2011
  ident: 2023013012234150500_B128
  article-title: Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwq193
– volume: 118
  start-page: 2098
  year: 2008
  ident: 2023013012234150500_B27
  article-title: Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI34584
– volume: 122
  start-page: 1615
  year: 2012
  ident: 2023013012234150500_B171
  article-title: The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI60644
– volume: 180
  start-page: 6836
  year: 2008
  ident: 2023013012234150500_B227
  article-title: Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.10.6836
– volume: 190
  start-page: 4116
  year: 2013
  ident: 2023013012234150500_B187
  article-title: Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating ß-glucan
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1202937
– volume: 122
  start-page: 839
  year: 2008
  ident: 2023013012234150500_B237
  article-title: Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.23101
– volume: 40
  start-page: 14
  year: 2009
  ident: 2023013012234150500_B256
  article-title: Targeting to porcine sialoadhesin receptor improves antigen presentation to T cells
  publication-title: Vet. Res.
  doi: 10.1051/vetres:2008052
– volume: 37
  start-page: 1076
  year: 2012
  ident: 2023013012234150500_B43
  article-title: Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.08.026
– volume: 128
  start-page: 1371
  year: 2011
  ident: 2023013012234150500_B245
  article-title: Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.25458
– volume: 17
  start-page: 4844
  year: 2011
  ident: 2023013012234150500_B260
  article-title: Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-11-0891
– volume: 30
  start-page: 705
  year: 2007
  ident: 2023013012234150500_B231
  article-title: In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model
  publication-title: J. Immunother.
  doi: 10.1097/CJI.0b013e31812e6256
– volume: 34
  start-page: 9589
  year: 2016
  ident: 2023013012234150500_B266
  publication-title: J. of Clin. Oncol
  doi: 10.1200/JCO.2016.34.15_suppl.9589
– volume: 11
  start-page: e0155189
  year: 2016
  ident: 2023013012234150500_B280
  article-title: Low mutation burden in ovarian cancer may limit the utility of neoantigen-targeted vaccines
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0155189
– volume: 167
  start-page: 1301
  year: 2005
  ident: 2023013012234150500_B270
  article-title: Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)61217-5
– volume: 348
  start-page: 69
  year: 2015
  ident: 2023013012234150500_B276
  article-title: Neoantigens in cancer immunotherapy
  publication-title: Science
  doi: 10.1126/science.aaa4971
– volume: 112
  start-page: 3264
  year: 2008
  ident: 2023013012234150500_B28
  article-title: The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
  publication-title: Blood
  doi: 10.1182/blood-2008-05-155176
– volume: 186
  start-page: 1218
  year: 2011
  ident: 2023013012234150500_B152
  article-title: Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000808
– volume: 108
  start-page: 2384
  year: 2011
  ident: 2023013012234150500_B194
  article-title: Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to langerin, DEC205, and Clec9A
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1019547108
– volume: 118
  start-page: 4111
  year: 2011
  ident: 2023013012234150500_B226
  article-title: Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation
  publication-title: Blood
  doi: 10.1182/blood-2011-04-346957
– volume: 119
  start-page: 6052
  year: 2012
  ident: 2023013012234150500_B163
  article-title: DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
  publication-title: Blood
  doi: 10.1182/blood-2012-01-406967
– volume: 39
  start-page: 925
  year: 2013
  ident: 2023013012234150500_B107
  article-title: Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.10.004
– volume: 118
  start-page: 261
  year: 2002
  ident: 2023013012234150500_B129
  article-title: DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif
  publication-title: J. Invest. Dermatol.
  doi: 10.1046/j.0022-202x.2001.01633.x
SSID ssj0003260
Score 2.4815326
SecondaryResourceType review_article
Snippet Review of in vivo targeting of tumor antigens to lectin receptors on antigen‐presenting cells using antibodies or ligands may improve the antitumor efficacy of...
There is a growing understanding of why certain patients do or do not respond to checkpoint inhibition therapy. This opens new opportunities to reconsider and...
Review of in vivo targeting of tumor antigens to lectin receptors on antigen-presenting cells using antibodies or ligands may improve the antitumor efficacy of...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1017
SubjectTerms Animals
Antibodies
Anticancer properties
Antigen (tumor-associated)
antigen presentation
Antigen-presenting cells
Antigens
Antitumor activity
Cancer
Cancer vaccines
Cancer Vaccines - genetics
Cancer Vaccines - immunology
Cancer Vaccines - therapeutic use
Carbohydrates
Cytotoxicity
Dendritic cells
Dendritic Cells - immunology
Humans
Immune checkpoint
Immune response
Immune system
Immunotherapy
Lectins
Lectins, C-Type - genetics
Lectins, C-Type - immunology
Lymphocytes
Lymphocytes T
Macrophages
Neoplasms - genetics
Neoplasms - immunology
Neoplasms - therapy
Priming
Receptors
Reviews
T cell receptors
T cells
T-Lymphocytes, Helper-Inducer - immunology
Vaccines
Title Targeting C‐type lectin receptors: a high‐carbohydrate diet for dendritic cells to improve cancer vaccines
URI https://onlinelibrary.wiley.com/doi/abs/10.1189%2Fjlb.5MR0217-059RR
https://www.ncbi.nlm.nih.gov/pubmed/28729358
https://www.proquest.com/docview/1983432015
https://www.proquest.com/docview/1922507397
https://pubmed.ncbi.nlm.nih.gov/PMC5597514
Volume 102
WOSCitedRecordID wos000413396400008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1938-3673
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003260
  issn: 0741-5400
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB9qq-CLH60f0VpWEB-E2CS7ud34Vk8PkVrK0cK9hf0KjdRcubsW7s0_wb_Rv8SZTS54HCiCL3nZj5DNzOxvZ2Z_A_DK2ApFN_Wo4lbGwmkRK5GZWHNrczXQMnUmFJuQJydqMilOt2C4ugvT8kP0DjfSjGCvScG16aqQKOLI_Hpp3uZfxoSpY8QI4_Et2ElTLkm0M3Ham2PEJ0nLxZlSFsAqtImTHG5Msb45bSDOzcTJ3wFt2JFG9__LtzyAex0gZUetBD2ELd_swt5Rg4fxb0v2moUU0eB734U7beXK5R40ZyGDHPc9Nvz5_Qc5chkFAOqGoQn1V1TD5x3TjNiQsd3qmZleLB3xUjBX-wVDrMzQ5LlQaYFR-GDOFlNWBx-HZ5aEccZutKXA__wRnI8-ng0_xV3phtgSo1-cF5VUwgthtdDGuFTqQWLyPOcmUVJntsoqoTNuHdcFL3Kn00pwW-XOpQObCP4Ytptp458C487YQYY2WadaDLzTiDqsqHBmKT13KoJk9c9K2_GaU3mNyzKcb1RR4uqW3eqWYXUjeNMPuWpJPf7UeX8lCGWn3_MyLRTdyEUsFcHLvhk1k9ZLN356TX3QVlIgVEbwpJWb_m14Ts0oAh2BXJOovgOxfq-3NPVFYP-mIyCi3AgOg0T9_QPKz8fvyfA---cRz-FuRigm5C7uw_Zidu1fwG17s6jns4OgZviUE3UAOx_Go_PjXxmKMUk
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6VFAQXHi0UQ4FFQhyQ3Pqx9trcSktUII1QlEq9WfuyatQ6VZJWyo2fwG_klzCzdiyiSCAkzvuwdj0z--3M7DcAb5QuUXRDiyquhc-N5H7GI-XLWOskS6UIjXLFJsRwmJ2d5V834Gj5Fqbhh-gcbqQZzl6TgpNDutHyjEgyv12oveRkRKDaR5AwGt2CTY7ilPRg82jUPx10FhkhStDQcYaUCLCMbuI0-2uTrJ5Pa6BzPXfyd0zrDqX-g_-znIdwvwWl7KCRokewYest2D6o8UJ-uWBvmUsTdf73LbjTVK9cbEM9dlnkePaxw5_ff5Azl1EQoKoZmlF7RXV83jPJiBEZ27Wcqsn5whA3BTOVnTPEywzNnnHVFhiFEGZsPmGV83NYpkkgp-xGagr-zx7Daf_j-PDYb8s3-JpY_fwkL0XGLedacqmUCYVMA5UkSayCTMhIl1HJZRRrE8s8zhMjw5LHukyMCVMd8PgJ9OpJbZ8Ci43SaYR2WYaSp9ZIRB6alzizEDY2mQfB8qcVuuU2pxIbF4W742R5gbtbtLtbuN314F035Koh9vhT592lJBStjs-KMM_oVS7iKQ9ed82onbRfsraTa-qD9pKCocKDnUZwuq_hXTWiKLQHYkWkug7E_L3aUlfnjgGcroGIdD3YdyL19wUUnwcfyPg---cRr-Du8fhkUAw-Db88h3sRoRqXy7gLvfn02r6A2_pmXs2mL1ut-wXdnzQ-
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9NAEB6VcogXjpbDUGCREA9IprZ37bV5Ky0RR4miqEh9s_ayalScKEkr5Y2fwG_klzCzdiyiSCAknvewdj0z-83O7DcAL7SpUHRjhypuZCisEmEuEh0qbkyaZ0rGVvtiE3I4zE9Pi9EWHK3ewrT8EP2FG2mGt9ek4G5qq1bLcyLJ_HquX6efxwSqQwQJ4_EVuCpStLXE7yxGvT1GgBK1ZJwxpQGsYps4yf7GFOun0wbk3Myc_B3R-iNpcPv_LOYO3OogKTtoZegubLlmB3YPGnTHvy3ZS-aTRP3t-w5cb2tXLnehOfE55HjyscOf33_QVS6jEEDdMDSibkpVfN4wxYgPGduNmunJ2dISMwWztVswRMsMjZ71tRYYBRDmbDFhtb_lcMyQOM7YpTIU-p_fgy-DdyeH78OueENoiNMvTItK5sIJYZRQWttYqizSaZpyHeVSJaZKKqESbixXBS9Sq-JKcFOl1saZiQS_D9vNpHEPgXGrTZagVVaxEpmzCnGHERXOLKXjNg8gWv200nTM5lRg47z0Hk5elLi7Zbe7pd_dAF71Q6YtrcefOu-tJKHsNHxexkVOb3IRTQXwvG9G3aT9Uo2bXFAftJYUCpUBPGgFp_8aeqoJxaADkGsi1Xcg3u_1lqY-8_zf5AQizg1g34vU3xdQfjx-S6b30T-PeAY3RkeD8vjD8NNjuJkQpPGJjHuwvZhduCdwzVwu6vnsqVe5X7avMic
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+C%E2%80%90type+lectin+receptors%3A+a+high%E2%80%90carbohydrate+diet+for+dendritic+cells+to+improve+cancer+vaccines&rft.jtitle=Journal+of+leukocyte+biology&rft.au=Dinther%2C+Dieke&rft.au=Stolk%2C+Dorian+A.&rft.au=Ven%2C+Rieneke&rft.au=Kooyk%2C+Yvette&rft.date=2017-10-01&rft.pub=Society+for+Leukocyte+Biology&rft.issn=0741-5400&rft.eissn=1938-3673&rft.volume=102&rft.issue=4&rft.spage=1017&rft.epage=1034&rft_id=info:doi/10.1189%2Fjlb.5MR0217-059RR&rft.externalDBID=10.1189%252Fjlb.5MR0217-059RR&rft.externalDocID=JLB1017
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0741-5400&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0741-5400&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0741-5400&client=summon